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Cytoskeletal regulation is a fundamental and crucial function of the cell that 
requires the co-ordination of several intracellular signaling pathways. It is a 
challenge to dissect these pathways not only owing to the large number of 
cytoskeletal proteins involved but also because of their dynamic regulation both 
biochemically and mechanically. Cytoskeletal reorganization is important in 
physiological phenomena such as embryonic development, muscle function, 
wound healing and immune response as well as in pathological phenomena such 
as tumour formation and metastasis. 
Nitric oxide (NO) is an important signaling molecule whose role in cytoskeletal 
remodeling is gaining increasing attention. NO can modify the cytoskeleton by 
triggering multiple signaling pathways. For example, NO-induced phosphorylation 
of the cytoskeletal regulator VASP (VAsodilator Stimulated Protein) disrupts the 
binding of VASP to actin. NO modulates the RhoA-induced cytoskeletal 
contraction by several mechanisms.  Nevertheless, the precise function of NO in 
cytoskeletal regulation, particularly for cell migration, is still not understood. The 
effects of NO are cell-type specific. The function of NO is well-characterized in 
endothelial cells, where it contributes to vasorelaxation. However, the role of NO 
in cancer is complex and is poorly understood. NO has been shown to exert pro- 
as well as anti-tumour effects.  
In this work, we studied the interplay between NO signaling and cytoskeletal 
regulation, with cell culture experiments testing the role of NO in epithelial cell 
migration, and with computational simulations examining the dynamics of mutual 
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antagonism between NO and RhoA.  For the study of migration, we selected 
Hepatocyte Growth Factor (HGF)–induced scattering of epithelial cells, which is a 
simplified model of the Epithelial-Mesenchymal Transition (EMT) in tumour 
invasion and metastasis. Our experimental studies revealed that NO is important 
for the HGF-induced migration and that it could affect the focal adhesion turnover 
during cell migration. Further work demonstrated that phosphorylation of VASP 
mediated the effect of NO on cell-cell junction disruption during the HGF-induced 
scattering of epithelial cells. Our experimental results also include the mutual 
antagonism between NO and the small GTPase, RhoA in epithelial cells. The 
interplay between NO and RhoA is complex and rises several questions that can 
be addressed by computational modeling.  
Our theoretical simulations of the NO-RhoA crosstalk suggested that their mutual 
antagonism could create a short-lived dynamic instability in the system. We found 
that the system is capable of bistability, converging either to a steady state with 
high NO levels and low RhoA activity, or to a steady state with low NO levels and 
high RhoA activity. Furthermore, the robustness of their bistability increased 
greatly upon integrating the RhoA-tension feedback and the tension inhibitory 
reaction of NO.!  Since NO and Rho are master regulators of cell relaxation and 
contraction respectively, this work sheds light on important new questions of 
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Chapter 1. Introduction 
! K!
1.1 Introduction !
In this work, we have studied the effect of NO signaling on cytoskeletal 
regulation, with cell culture experiments testing the role of NO in epithelial cell 
migration, and computational simulations examining the dynamics of mutual 
antagonism between NO and RhoA. NO has been well-studied in the 
cardiovascular system (endothelial and smooth muscle cells) where it acts as 
a vasodilator. The cytoskeletal regulation by NO in epithelial cells is still not 
clear and needs to be resolved to better understand phenomena such as 
Epithelial-Mesenchymal Transition (EMT). EMT occurs during cancer 
metastasis and also during embryo development. HGF-induced epithelial cell 
scattering is widely used as a model system to study EMT and facilitates the 
study of the two events in EMT: cell-cell junction disruption and focal 
adhesion turnover. The role of NO in HGF-induced epithelial cell scattering 
has never been studied before. !
VASP is an actin-binding protein that localizes to cell-cell contacts and focal 
adhesions. Our experimental studies report for the first time that HGF induces 
VASP-Ser239 phosphorylation. NO is known to mediate VASP 
phosphorylation at Ser239 through the cGMP/PKG pathway and we show 
that, in a similar manner, NO mediates the phosphorylation of VASP in HGF-
induced epithelial cells. The functional implication of NO-induced VASP-
Ser239 phosphorylation on cell-cell junctions has never been identified 
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before. We find that the eNOS-mediated VASP-Ser239 phosphorylation 
contributes to cell-cell junction disruption during HGF-induced scattering of 
epithelial cells. This finding sheds light on the role of NO-induced VASP 
phosphorylation in EMT. 
The literature is rich with information on the biochemical signaling pathways of 
NO, but the spatiotemporal regulation of NO signaling remains to be 
elucidated. We have used fluorescence microscopy techniques to discern the 
role of NO in cytoskeletal regulation during collective cell migration 
spatiotemporally. NO has largely been studied, either in cells with high NO 
level such as endothelial cells and transformed cancer cells or with the help of 
NO donors which induce non-physiological levels of NO in the cell. We have 
induced physiological level of NO in untransformed epithelial cells (MDCK 
cells) using growth factor and then inhibited NO to study its effects. 
Focal adhesion turnover is needed for motility during scattering. The 
spatiotemporal regulation of focal adhesion turnover is mediated by yes-or-no 
decisions of the cell whether to assemble focal adhesions or not. NO has 
been shown to mediate focal adhesion disassembly in endothelial cells [1] as 
well as in our preliminary experiment in epithelial cells. On the other hand, 
RhoA is needed for focal adhesion growth[2]. Thus NO and RhoA are two 
species with opposite effects on focal adhesion turnover and hence must be 
regulated spatiotemporally by the cell.  
RhoA and NO are master regulators of cell contraction and relaxation 
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respectively, but little work has studied their interplay. On integrating several 
biochemical pathways from literature, we observed that there are multiple 
mechanisms by which RhoA/ROCK pathway inhibits the eNOS/NO pathway 
[3-5]. However, the opposite effect of NO inhibiting RhoA [6-8] was not shown 
in the same study or in the same cell type.  Hence we first confirmed 
experimentally that NO and RhoA antagonize each other in the same cell 
type. Previous computational systems biology models with NO and RhoA 
have not addressed their mutual antagonism [9]. Mutual antagonism is a 
common motif for bistability. Bistability in a signaling network allows the cell to 
make yes-or-no responses to environmental cues and we were interested to 
explore the possibility of bistability in the NO-RhoA interplay. Our theoretical 
simulations show that the NO-RhoA signaling network is capable of bistability 
and also characterize the bistability. We further find that mechanical tension is 
an important contributor to the robustness of the bistability in the NO-RhoA 
network. Studying the bistability in the NO-RhoA network could help to 
understand the spatiotemporal regulation of focal adhesion turnover during 
migration. 
Thus, our work sheds light on the role of NO signaling in cytoskeletal 
regulation of epithelial cell scattering, through VASP phosphorylation using an 




1.2 Brief overview of Cell Migration and the Actin Cytoskeleton 
 
Cell migration is a multi-step process which involves surface protrusion, 
substrate attachment, retraction of cell body, and substrate detachment [10]. 
During surface protrusion, sheet-like (lamellipodium) and finger-like (filopodium) 
membrane structures are formed at the leading edge of the cells [11]. These 
structures are actin-based extensions of the cells (Figure 1.1), and they are the 
key structural elements that drive cell spreading and migration [12].  
Actin cytoskeleton and the regulators of actin dynamics are vital components of 
the protrusive machinery of cell motility [11]. The intrinsic property of polarized 
actin filaments to polymerize at fast-growing “barb” ends and slow-growing 
“pointed” ends is the major driving force of membrane protrusion [13]. Several 
actin-binding proteins regulate actin polymerization. The unbranched actin 
filaments are elongated by many proteins, which include the vasodilator-
stimulated phosphoprotein family (Ena/VASP) proteins [14]. The activity of the 
small GTPase, RhoA increases myosin activity and contraction, which is 









Figure 1.1 Actin-based structures.  
The cell is migrating upwards and is attached to a second cell on the right. (inset 
filopodium, lamellipodium and lamellum). (Modified from Gapter et al. 2011; 




After the initial stage of actin-mediated cell protrusion, the basal 
membrane of the cell attaches to the extra-cellular matrix through a physical 
linkage between the substrate and integrins, a class of cell adhesion receptors 
[15]. On activation either by internal or external signals, clusters of activated 
integrin and more than 50 proteins form structures called focal contacts and focal 
adhesions in the basal membrane of the cells, which are tethered to actin 
filaments [16]. Focal contacts and focal adhesions act as points where traction 
force is exerted during cell migration.  
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Collective cell migration and HGF-induced scattering of cells 
Collective cell migration is more complex and involves more factors than 
single cell migration [17]. The major hallmark is that during collective cell 
migration the cells maintain cell-cell adhesion integrity [18]. Hepatocyte Growth 
Factor (HGF) causes collective epithelial cell colonies to dissociate from each 
other and migrate as single cells, in a phenomenon called scattering, which is a 
model for a developmental process called Epithelial-Mesenchymal Transition 
(EMT), which also occurs in some cancers [19].  
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1.3 Nitric oxide 
1.3.1 Complex role of NO in cancer and metastasis 
The synthesis of Nitric oxide (NO) from L-arginine, NADPH and oxygen is 
catalyzed by Nitric oxide synthases (NOS) [20]. Both NO and NOS are 
ubiquitously expressed in malignant tumours and have been shown to exert pro- 
as well as anti-tumour effects (reviewed in [21]) . Some factors that determine the 
effect of NO on tumours seem to be: intracellular localization of NOS and its 
activity, amount and time of NO exposure and sensitivity of cells to NO [21]. The 
role of NO in cancer is complex and is poorly understood.  
The Table 1.1 has been adapted from Table I in the review by Burke et al [22] 
and summarizes the studies done on the role of NO in cancerous phenomena 
such as EMT, metastasis and invasion. Cytoskeletal regulation and migration are 
central to all these phenomena.   
From the Table 1.1, it can be seen that the results are contradictory for the 
function of NO in EMT and metastasis. Some of them report that NO increased 
metastasis and EMT while some others report the opposite effects. Different 
methods of NO modulation have been employed in different cell types, which 
could be the reason for these contradictory results. All the studies have been 
done in different cancer cell lines, which could have varying sensitivities to NO. 
The chemicals that have been used in some studies listed in the Table 1.1 are : 
SNAP(S-Nitroso-N-acetyl-DL-penicillamine) , DETA/NO(Diethylenetriamine NO) 
! "7!
and JS-K which are NO donors; L-NAME(L-NG-Nitroarginine Methyl Ester) is a 
NOS inhibitor. The concentration and half-life of NO produced by the different 
donors can differ greatly. The efficacy of the inhibitor can also vary with the 
concentration used and treatment duration.  
Table 1.1 Summary of effects of different methods of NO modulation in 
EMT and metastasis.  
(Adapted from Table I in Burke et al, [22]).  
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Alveolar cells 2mM L-NAME induced EMT Decrease EMT [32] 
Prostate 
metastatic cells 1000 µM DETA/NO Inhibit EMT [33] 
Skin tumors 











cancer cells 500 µM DETA/NO Inhibit MMP-9 [36] 
HCC 1806 breast 
cancer cells 





The biphasic nature of NO-mediated effects in cancer depends upon the 
concentration of NO, the duration of NO exposure and cellular sensitivity to NO. 
The above review highlights the need to conduct NO studies in simple, in vitro 
model systems for better control over the experimental conditions. Studies of NO 
in untransformed epithelial cells rather in transformed cancer cell lines (with non-
physiological NO level or with a varying level of sensitivity to NO) can help us 
better understand the functions of NO in cell migration. 
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1.3.2 Synthesis, Signaling and Regulation of NO 
Synthesis of NO 
The synthesis of Nitric oxide (NO) from L-arginine, NADPH and oxygen is 
catalyzed by Nitric oxide synthases (NOS) [20].  The three NOS isoforms are 
neuronal NOS (nNOS), inducible NOS (iNOS) and endothelial NOS (eNOS). 
nNOS and eNOS are constitutively expressed enzymes, collectively referred to 
as constitutive NOS (cNOS) [20].  eNOS was first discovered in the vascular 
endothelium but is also found in neurons, epithelial cells and cardiac myocytes. 
nNOS is present in neurons, skeletal muscle cells and epithelial cells. iNOS is 
induced by cytokines and endotoxins in response to inflammation in several cell 
types. iNOS can generate more NO than cNOS [38].  
NO-induced post-translational modifications and signaling pathways 
NO is highly unstable and has a half-life of 1-5 seconds in vivo [39]. NO can 
trigger many signaling pathways via increased cyclic Guanosine MonoPhosphate 
(cGMP) synthesis or by post-translational modifications of proteins, such as S-
nitrosylation or nitration. NO can also interact with reactive oxygen species such 
as superoxide radicals to generate peroxynitrite, nitrogen dioxide and reactive 
nitrogen species [40]. This indicates the highly reactive nature of NO.  
Regulation of NO 
NO, being a highly reactive and diffusive molecule requires spatiotemporally 
controlled synthesis and release (Reviewed in [41]). Though the NOS isoforms 
share similar structures and catalytic modes, they are regulated by diverse 
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mechanisms. cNOS activity depends on cytosolic calcium concentration which 
increases on several physiological stimuli and can facilitate calmodulin binding to 
cNOS upon which the cNOS dimer is activated and can produce NO [20].  eNOS 
activity is also regulated by its intracellular localization, other regulatory binding 
proteins and phosphorylation status (at serines 617,635 and 1179 for activation; 
at threonine 497 for inhibition) [42]. On the other hand, iNOS is regulated by 
transcription and induced by cytokines [38].  
Spatial regulation of NOS 
The differential subcellular localization of the NOS enzymes in cardiomyocytes 
has been found to have distinct effects of NO in the function of the heart [41]. 
Lipid modifications such as myristoylation and palmitoylation target eNOS to the 
plasma membrane and golgi complex. Several studies suggest that eNOS is 
more efficient in synthesizing NO at the plasma membrane [43]. eNOS is 
inhibited in caveolae by binding to the caveolin proteins (caveolin-1 and caveolin-
3) [44]. eNOS resides at cell-cell contacts by binding to PECAM-1 [45, 46]. eNOS 
has also been found to associate with the cytoskeleton by direct binding to actin, 
the mechanism of which is not yet known [47].   
iNOS can be palmitoylated but not myristoylated and is thus targeted to the 
plasma membrane [48]. iNOS is also regulated by associating with caveolin-1 
which lowers the enzyme stability [49]. Unlike eNOS and iNOS, nNOS does not 
get acylated and is targeted to membranes in neurons by protein-protein 
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interactions involving its unique PDZ domain which is absent in the other NOS 
isoforms [50].  
 
1.3.3 Role of NO in Cytoskeletal Regulation and Migration:  
As discussed earlier, the effects of NO are bimodal and cell-type specific. Several 
published studies on NO and cell migration in the past have used high 
concentrations of NO donors which released non-physiological levels of NO, 
which could either damage the cell or trigger complex feedback pathways. The 
usage of well-established NO or NOS inhibitors can yield a relatively better 
understanding of how NO functions in the cell.  
 Studies that have studied NO by inhibiting the endogenous NO have reported 
that NO is needed for migration by in epithelial cells [51], human breast cancer 
cells [52] and endothelial cells [53]. In recent studies that have used physiological 
levels of NO to treat cells, it has been demonstrated that NO is necessary for 
migration of endothelial progenitor cells [54] and colon cancer cells[55]. These 
different studies indicate the positive role of endogenous NO in cell migration. 
However, these findings have not been corroborated with the mechanism by 
which NO regulates cytoskeletal proteins.  
NO-induced modifications of cytoskeletal proteins 
We have summarized the previous work done on the effect of NO on cytoskeletal 
proteins in Table 1.2. We have classified the studies by the nature of post-
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translational modification induced in the protein by NO such as nitration, S-
nitrosylation and phosphorylation.  
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From the Table 1.2, we find that the studies on nitration and S-nitrosylation fall 
into one or more of the following categories: 
1. The cells have been treated with very high concentration of NO donor. 
2. The cells have been exposed to NO for a long duration. 
3. The NO-induced nitration and S-nitrosylation of cytoskeletal proteins disrupt 
the cytoskeleton. 
Our work consists mainly of the NO/cGMP-dependent phosphorylation of 
cytoskeletal proteins, as very high concentration of NO donors is not needed to 
induce the cGMP cascade of reactions. The NO/cGMP pathway is triggered by 
low NO level induced by growth factors such as VEGF and HGF. Tyrosine 
nitration of proteins requires very high concentration of NO, which can be toxic to 
the cells [67]. S-nitrosylation is an important post-translational modification, which 
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needs further study in the future. There is growing evidence that S-nitrosylation 
occurs at physiological conditions[68-70]. To study S-nitrosylation, other 
techniques such as the biotin switch assay are required, which were not available 
or optimized for our study. The biotin switch assay is not suitable to study the 
spatial effects of NO. Hence we focused on NO/cGMP/PKG-induced 
phosphorylation of the cytoskeleton.  
HGF and NO signaling 
HGF stimulates NO production by eNOS-Ser1177 phosphorylation which is 
mediated by the phosphoinositide 3-kinase(PI3K)/Akt pathway in endothelial 
cells[71, 72]. HGF-induced NO has been shown to promote cell motility in 
endothelial cells[73], epithelial cells [51] and trophoblasts [74]. However the 
mechanism by which HGF-induced NO modifies the cytoskeleton to increase the 
motility is not clear.  
The next part of the thesis reviews the protein, VASP, which is a known 











The Ena/VASP family of proteins, which includes vasodilator-stimulated 
phosphoprotein (VASP), the !"#$#%&'() protein Enabled (Ena), its mammalian 
homologue Mena, and the Ena-VASP-like protein (Evl) [75], has been implicated 
in a range of processes dependent on cytoskeletal remodeling and cell polarity. 
VASP, an actin-binding protein, is phosphorylated at Ser239 by the 
NO/cGMP/PKG pathway. VASP-Ser239 phosphorylation has been used as a 
marker for NO/cGMP/PKG signaling in endothelial cells[76] and in cancer 
cells[77].  
Ena/VASP proteins localize to the lamellipodia, filopodial tips, focal adhesions as 
well as cell-cell junctions in several cell-types. VASP is also present in bacterial 
pathogens such as Listeria monocytogenes that utilize the actin cytoskeletal 
machinery in the host to generate virulent motion. Though VASP plays an 
important role in migration and cell-cell junction formation, the phosphoregulation 
of VASP in cytoskeletal regulation is not understood.  
 All the proteins of the Ena/VASP family share a common domain structure of a 
central proline-rich region flanked by two highly conserved Ena-VASP homology 
domains (EVH1 and EVH2). The central proline-rich region of Ena/VASP proteins 
is recognized by the G-actin binding protein, profilin [75, 78] and the EVH2 
domain mediates F-actin binding as well as VASP oligomerization [75, 79, 80]. 
Hence the Ena/VASP family of proteins regulate cytoskeletal dynamics by 
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mediating actin filament nucleation [80], profilin and G-actin recruitment [78, 81], 
anti-capping [82, 83] and filament bundling [84]. These effects may be 
potentiated by oligomerization of VASP.  
Although the structures of VASP, Mena and EVL suggest overlapping functions, 
they also have distinct properties and regulatory mechanisms. The EVH1 domain 
and parts of the EVH2 domain are homologous, however, the central region 
differs both in length and proline content [85]. The number of conserved cyclic 
nucleotide-dependent kinase phosphorylation sites in VASP, Mena and EVL is 
three, two and one respectively [75]. VASP and EVL were found to have different 
actin-nucleating capacities in vitro. [85].  
1.4.2 Role of VASP in Cancer and Metastasis 
The actin cytoskeletal network plays a vital role in the invasive properties of 
oncogenic cells. Therefore, proteins functionally linked to actin can also be 
expected to contribute to the increased invasiveness of tumour cells. VASP was 
found to be overexpressed in lung adenocarcinoma cells when compared to 
normal lung cells [86]. Liu et al reported that overexpression of VASP in NIH3T3 
fibroblasts induced neoplastic transformation [87]. On the other hand, down-
regulation of VASP led to loss of contact inhibition, continued cell division and 
potential tumorigenesis [87].  
The phosphorylation status of VASP is also known to be impaired in some 
malignancies. Decreased expression of PKG in platelets and therefore, reduced 
VASP phosphorylation was observed in patients with chronic myelocytic 
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leukemia [88]. Though these evidences link VASP to metastasis, the underlying 
molecular mechanism is still not clear.  
1.4.3. Role of VASP in Cytoskeletal Regulation 
VASP and cell-cell junction 
Ena/VASP has been shown to mediate several cell-cell adhesion processes in 
addition to its role in regulating actin cytoskeletal dynamics for cell motility. 
Ena/VASP proteins localize to cadherin-enriched cell-cell contacts between 
primary murine keratinocytes [89] as well as between the follicular cells of the 
egg chamber in the developing Drosophila embryo [90]. E-cadherin homophilic 
ligation is necessary to recruit VASP to cell-cell contacts [91]. Vinculin and Zyxin 
recruit VASP to the cadherin-mediated cell-cell contacts where VASP provides an 
indirect mechanism to link the adherens junction to the actin cytoskeleton [92] 
(illustrated in Figure 1.2). 
Actin assembly at cell-cell contacts requires Ena/VASP activity [90, 91]. 
Disrupting the function of Ena/VASP affects the cadherin-based actin 
organization in CHO cells [91]. Ena/VASP proteins are crucial for epithelial 
zippering during dorsal closure in Drosophila. Disrupting VASP function failed to 
seal the cell-cell contacts during the closure [93]. It has been well established 
that Ena/VASP is critical for sealing cell-cell contacts and regulating the 
endothelial barrier permeability, both in vitro and in vivo [94-97].  
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Figure 1.2 Schematic model of an epithelial adherens junction  
(Adapted from Figure 1 from Vasioukhin et al [92]). The black arrow points to 
VASP. The symbols and their meanings are explained in the legend below. 
VASP is recruited to the cadherin-mediated adherens junction by vinculin and 
links the AJ to the actin cytoskeleton. β-catenin and α-catenin are components of 
the AJ, linking E-cadherin directly with actin. 
 
VASP has also been implicated in tight junction formation [98] by means of 
regulating the recruitment of ZO-1 [99]. Another mechanism by which VASP can 
mediate the cortical actin assembly is by interacting with spectrin [94]. Thus, 
VASP plays an important role in cell-cell junction formation and regulation by 
different mechanisms.  
Ena/VASP proteins are also recruited to the lamellipodia and focal adhesions in 
different cell types such as fibroblasts [75, 100], endothelial cells [101], epithelial 
cells [102] and vascular smooth muscle cells [103]. The next part discusses the 
function of VASP in the lamellipodia and focal adhesions.  
VASP at focal adhesions and stress fibres 
Focal adhesions are needed for cell adherence to the substrate. VASP is 
recruited to focal adhesions via its EVH1 domain by several FP4-motif-containing 
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proteins such as zyxin, vinculin, palladin and RIAM [104]. VASP is also recruited 
to actin stress fibers by zyxin and palladin[104].  The precise function of VASP in 
regulating focal adhesions and stress fibers is unknown. 
Lamellipodia 
Cell migration requires lamellipodial extension that is an actin polymerization-
driven process. VASP is recruited to the lamellipodia by lamellipodin [105], RIAM 
and the cadherin Fat1 [104]. Ena/VASP aids in actin filament elongation by 
antagonizing the actin filament capping proteins [83]. The accumulation of 
Ena/VASP at the leading edge increased the lamellipodial protrusion rate [106]. 
However, fibroblast cells lacking all endogenous Ena/VASP proteins translocated 
faster [107]. Cells in which all Ena/VASP proteins were sequestered on the 
mitochondrial surface moved faster than cells in which VASP was targeted to the 
plasma membrane [107]. This seemingly paradoxical behavior of VASP led to 
more studies on its function in lamellipodia.  
The studies that followed showed that Ena/VASP-deficient lamellipodia protruded 
slower, were more persistent and had a highly branched actin network [83]. Since 
migration comprises of several cycles of lamellipodial protrusion and retraction, 
lamellipodial persistence is correlated more with the net translocation rate of the 
whole cell than lamellipodial protrusion rate [83], which explains why VASP-null 
cells move fast. Ena/VASP causes lamellipodia to elongate rapidly but with less 
persistence and hence the whole cell migration speed decreases. Rapidly 
protruding and less persistent lamellipodia cause membrane ruffling, which can 
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help the cell to explore its environment. Consistently, Ena/VASP modulates 
PDGF-induced dorsal membrane ruffling [108]. 
1.4.4 Regulation of VASP Function by Phosphorylation 
Phosphorylation of VASP regulates its binding to actin as well as its subcellular 
targeting. VASP is a major substrate for both cAMP and cGMP-dependent 
kinases, which are PKA and PKG respectively. The three common PKA/PKG 
phosphorylation sites in human VASP have been identified to be Ser-157, Ser-
239, and Thr-278. Ser-157 is located in the central proline-rich (profilin-binding) 
region of VASP. Ser-239 is located in the EVH2 domain, downstream of the G-
actin binding (residues 234-237) region while Thr-278 is downstream of the F-
actin binding (residues 259-276) region [101]. The first two sites are conserved in 
Mena, whereas Ena has only Ser-157 [75]. Although Ser-157 and Ser-239 can 
be phosphorylated by both PKA and PKG, PKA primarily phosphorylates Ser-157 
and Ser-239 is the primary target for PKG. AMPK phosphorylates Thr-278. 
VASP is known to be tightly and reversibly regulated by phosphorylation. The 
VASP phosphorylation status is known to regulate its interaction with other 
proteins, the subcellular localization of VASP as well as its role in migration and 
cell-cell contacts.  
VASP phosphorylation at Serine 239 disrupts its binding to actin 
Phosphorylation of VASP, especially at Ser-235 (which is the Ser-239 equivalent 
site in murine VASP), affected its interaction with actin in vitro [109] and 
contributed primarily to the loss of the anti-capping activity of VASP in vitro [82].  
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Phosphorylation at Ser-239 and Thr-278 synergistically impaired VASP-driven 
actin assembly in vitro as well as cellular F-actin accumulation in vivo [101]. 
Pseudophosphorylation at the VASP S239 homologous site in Mena (S376) also 
impaired F-actin accumulation in vivo [101]. Phosphorylation at Ser-157 affected 
the binding of VASP to SH3 domain but did not affect its binding to profilin or 
actin [75, 85, 109-111].  
VASP phosphorylation regulates localization of VASP 
For ease of comparison, the following references have been tabulated in Table 
1.3. It has been shown in endothelial cells that PKA-induced phosphorylation at 
Ser157 enhanced VASP localization at cell-cell contacts [94, 99] and at 
lamellipodia and focal adhesions [101]. NO-induced VASP phosphorylation at 
Ser239 redistributed VASP to the leading edge of migrating microvascular 
endothelial cells [54]. In another study, phosphorylation at both Ser-157 and Ser-
239 translocated VASP to periphery in human umbilical vein endothelial cells 
(HUVECs) [112].  
By contrast, in the same cell line (HUVECs), phosphorylation of VASP detached 
it from focal adhesions and translocated VASP in the reverse direction - from 
periphery to cytosol. The detachment was inhibited only if all the three residues 
(Ser-157, Ser-239,Thr-278) were mutated, suggesting that all three residues are 
important [113]. Similarly, PKG-induced phosphorylation at Ser239 decreased 
VASP localization at lamellipodia of renal epithelial cells [102]. Hence there are 
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contradictory results from different methods for studying the effect of Ser239 
phosphorylation on the spatial regulation of VASP. 
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Role of VASP-Ser239 phosphorylation in cytoskeletal regulation 
Similar to the reasons discussed earlier for NO(Section 1.1.1), different 
experimental conditions could be the reason for the  contradictory results in the 
effect of VASP-Ser239 phosphorylation on migration as well as on localization. 
For example, in the references [102, 113] (marked by arrows in Table 1.3), the 
cells were treated with a higher donor concentration as well as for a longer 
duration (30 minutes) when compared to the other studies. It can also be seen 
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that the role of NO-induced VASP-Ser239 phosphorylation in cell-cell 
contacts has not been studied before. 
VASP-Ser157 phosphorylation has been found to mediate the Platelet-Derived 
Growth Factor (PDGF)-induced migration of endothelial cells [114]. VASP-Ser239 
phosphorylation mediated the migration of PDGF-induced smooth muscle cells 
[103]. However the role of NO-induced VASP-Ser239 phosphorylation has not 
been studied in HGF-induced scattering of epithelial cells.  
NO-induced signaling pathways are dependent upon another important 
cytoskeletal regulator, RhoA. The next section of the thesis is a review on RhoA 








1.5.1 RhoA in cancer and metastasis 
RhoA is a well-known member of the Rho GTPases family and controls several 
fundamental processes of cell biology such as morphogenesis, polarity, migration 
and cell division. RhoA is implicated in cancer metastasis [115]. Although RhoA 
mutations have not been found in human cancers [116, 117], increased mRNA 
and protein levels of RhoA have been linked to several human cancers [118-
120]. Overexpression of RhoA induced the neoplastic transformation of human 
mammary epithelial cells by overcoming senescence checkpoints [121] while 
RhoA deficiency suppressed invasion by breast cancer cells [122]. Consistently, 
microRNA-31 (miR-31) suppressed breast cancer metastasis partly by 
downregulating RhoA gene expression [123]. The positive correlation between 
RhoA overexpression and cancer metastasis is well-documented [124, 125].  
Regulation of RhoA  
RhoA activation is regulated by several mechanisms including the activation of 
G-protein coupled receptors (GPCR). On agonist stimulation, RhoA converts from 
the inactive, GDP-bound form to the active, GTP-bound form. The activation of 
RhoA requires the translocation of inactive, cytosolic RhoA to the membrane. 
Post-translational modifications such as geranygeranylation and phosphorylation 
regulate the activation and/or membrane translocation of RhoA [126].  
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1.5.2 RhoA and NO cross-talk 
The cross-talk between NO and RhoA is well-studied in the vascular system, 
where NO and RhoA exert opposite effects such as vasodilation and 
vasoconstriction respectively.  
NO/cGMP/PKG induces phosphorylation and inactivation of RhoA: 
In the vascular system, RhoA is activated downstream of stimulation by GPCR 
agonists. In this system, NO/cGMP/PKG signaling is shown to inhibit RhoA-
mediated contraction and actin organization [127]. It has also been demonstrated 
that the NO-induced vasodilation and changes in actin cytoskeletal organization 
are via inhibition of Rho kinase signaling [6, 127]. PKG-induced phosphorylation 
of RhoA at Serine 188 inhibits the membrane-translocation of GTP-bound RhoA 
and thus blocks the GPCR agonists-induced RhoA activation [6, 8].  
NO upregulates RhoA expression: 
On the other hand, phosphorylation at Serine 188 protects RhoA from 
ubiquitin/proteosome-mediated degradation [128]. Consistently, it has been 
suggested that basal NO release from endothelial cells is essential to maintain 
RhoA expression level in vascular smooth muscle cells [129]. It has been 
postulated that the elevated RhoA expression induced by NO could be due to a 
combination of translational and transcriptional upregulation of the RhoA gene as 
well as by decreased degradation of RhoA protein.  
Interestingly, a more recent study in diabetic rats reported a positive effect of NO 
on RhoA level [130]. In diabetic rat hearts, the NO-induced increase in RhoA 
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expression was not accompanied by increase in RhoA phosphorylation at Serine 
188. As a result, iNOS-derived NO upregulated expression and subsequent 
activation of RhoA, leading to RhoA/ROCK-mediated contractile dysfunction in 
diabetic rat hearts [130]. The discrepancy between this study reporting a positive 
effect of NO on RhoA and the previous studies reporting a negative effect of NO 
on RhoA could be due to the difference in experimental conditions. Experiments 
done in vivo, under pathophysiological conditions exhibit a different behaviour 
from experiments done in cultured cells.  
Other NO-induced post-translational modifications that regulate RhoA 
In addition to the cGMP-dependent effects of NO, RhoA is also inactivated by S-
nitrosation and the inactivation mediated the NO-induced smooth muscle cell 
anti-proliferation [131]. In another instance for cGMP-independent effect of NO, 
Caveolin-1 deficient mice exhibited eNOS hyperactivation and the high level of 
NO induced p190RhoGAP nitration and impaired its function. This led to the 
upregulation of RhoA activity and endothelial permeability [59]. Consistently, a 
recent study demonstrated that eNOS deficiency reduced RhoA activation and 
endothelial permeability, downstream of VEGF stimulus [65]. 
Effect of RhoA on NO 
The previous section reviewed on how NO regulates RhoA by different 
mechanisms. It is also known that RhoA can regulate NO at both expressional 
and post-translational levels. RhoA activates ROCK which downregulates eNOS 
mRNA stability and thus inhibits eNOS expression [4, 132]. At the post-
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translational level, RhoA/ROCK signaling inhibits PKB/Akt-mediated eNOS 
phosphorylation at Serine 1177 and thus downregulates eNOS activation and NO 
production [5]. The RhoA/ROCK-mediated inhibition of eNOS expression and 
activity caused erectile dysfunction in diabetic rats [3]. 
The above review demonstrates the complex regulation between NO and RhoA. 
As discussed in Section 1.3, VASP is a known target of NO/cGMP/PKG 
signaling. Hence we were interested in the mutual regulation of RhoA and VASP-
Ser239 phosphorylation.  
1.5.3 RhoA and VASP cross-talk 
We have reviewed in Section 1.3 that VASP-Ser239 phosphorylation is mediated 
by NO/cGMP/PKG signaling. Since NO and RhoA regulate each other by many 
mechanisms as discussed earlier, it is likely that VASP phosphorylation is also 
involved in this interplay. The cross-talk between RhoA and VASP-Ser239 
phosphorylation and its functional significance is not understood. RhoA activation 
was recently shown to mediate PKD1-induced phosphorylation of VASP at 
Ser157 and Ser322, translocating VASP from focal contacts to the leading edge 
in Human Embryonic Kidney (HEK-293) cells [133]. RhoA was also shown to 
induce PKA-mediated phosphorylation of VASP at Ser157 in HEK-293 cells in a 
ROCK-independent manner [112].  
VASP is known to regulate the activity of another small GTPase, Rac1. The 
mutual antagonism between RhoA and Rac1 is well studied [134-138]. VASP 
phosphorylation at Ser239 was demonstrated to increase Rac1 activity and thus 
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stabilized the endothelial barrier function [139]. It was also found that 
overexpression of dominant negative Rac1 (N17Rac1) decreased VASP-Ser239 
phosphorylation, indicating the existence of a feedback regulatory mechanism 
[139]. This leads to questions such as: (1) Does NO/PKG-induced VASP-Ser239 
phosphorylation antagonize RhoA activity indirectly by increasing Rac1 activity? 
(2) Does the RhoA/ROCK signaling regulate VASP-Ser239 phosphorylation?  
1.5.4 NO, RhoA and tension 
NO and RhoA are known to have opposite effects on cytoskeletal tension in the 
cell. The NO/cGMP pathway is known to inhibit tension by decreasing 
intracellular Ca2+ level, activating K+ channels and by activating Myosin Light 
Chain Phosphatase (MLCP) which dephosphorylates Myosin Light Chains 
(MLC), leading to relaxation [140]. On the other hand, RhoA phosphorylates MLC 
by activating ROCK and thus increases tension. Mechanical tension is needed to 
maintain high ROCK activity and this leads to a positive feedback mechanism to 
amplify and sustain ROCK activity [141].  
The above review of the NO-RhoA cross-talk is summarized in a simplified 
schematic (Figure 1.3) .The overview emphasizes that the cross-talk between 
NO and RhoA is complex and rises several questions that can be addressed by 






Figure 1.3 Schematic representation of the NO-RhoA-VASP cross-talk. 
The network of reactions mediating the cross-talk between NO,RhoA and VASP 













1.6 Computational Modeling of Cell Signaling Networks 
Computational modeling is an important tool to decipher the complicated 
biological interaction networks. In mathematical modeling, interaction networks 
are converted into mathematical models, which can then be simulated using 
computational software. Though a mathematical model is not an exact replica of 
the biological system, it can give insight into the biological pathway behavior. 
Computational modeling eases the burden on experimental setups, by predicting 
model behavior in the presence of certain perturbations to the system [142]. The 
predictions can then be validated experimentally, thereby narrowing the range of 
possibilities that a biologist would have to test.  
Depending on the results needed and the system complexity, model construction 
of biological pathways is varied. If in the model, the number of reactants is so 
great that the single reactant behavior cannot be distinguished from the system 
behaviour, then we can subject the enzyme kinetics to a mass action 
approximation. The distributions of reactants are assumed to be continuous (as 
opposed to discrete). In stochastic models, there is a specific probability 
associated with the occurrence of every reaction. However, since it is 
computationally intractable to analyze complex stochastic models with a large 
number of reactants, we use a deterministic approach. Though spatial behavior is 
modeled using Partial Differential Equations (PDE), these aspects can also be 
explored in a simpler manner using a compartmental Ordinary differential 
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equations (ODE) model. Hence ODE models, in most cases, suffice to facilitate a 
detailed analysis of the model [143]. 
1.6.1 Ordinary Differential Equations 
Ordinary differential equations (ODEs) are a commonly used mathematical 
representation of biological pathways. Converting the reaction equations into a 
differential equation preserves the time-based evolution of system. 
     A+B
! 
k" # " C 
The above reaction equation can be converted to differential equations by the 
use of mass action kinetics. As per the Law of mass action, the rate of formation 
of the product is proportional to product of the concentrations of species involved 
in the reaction, that is: 
       rate of formation of C = k*[A]*[B]  
The proportionality constant k is called a reaction rate or, a parameter. The 
change in concentration of the product over time is given by using a differential 
equation  
          
! 
dC
dt = k *[A]*[B] 
1.6.2 Steady State and Bifurcation Analysis  
More in-depth knowledge of model behavior is obtained by analyzing the 
dynamic nature of the ODEs.  The dynamic behaviour of the model can be 




ODEs can be simulated to give time-based trajectories of individual proteins 
concentrations. Over time, the concentration of these proteins reach a steady 
state, that is, when then is no further change in concentration of species over 
time.  
Bifurcation:  
As mentioned above, model systems have a single stable steady state, which is 
also called as a fixed point. Under certain conditions, for example, by changing 
some parameter values, these fixed points might become unstable. The 
combination of parameter values at which the behavior of the fixed point changes 
is called bifurcation. The theory can be compared to a bifurcation/fork in a road, 
which would cause a free rolling ball to change directions [144].  Bifurcation 
analysis is the study of the dependence of the system on parameter values.  
1.6.3 Bistability 
Bistability is a biologically well-studied type of bifurcation. As the name suggests 
the system has two bifurcation points where the stable points change into 
unstable points. The fate of the cell is determined by decisions based on complex 
signaling networks. Bistability in a signaling network allows the cell to make yes-
or-no responses to environmental cues. A bistable system can rest in one of two 
distinct, stable steady states but cannot rest stably in intermediate states. Each 
of these steady states corresponds to a decision. In response to proper stimulus, 
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the system can act as a robust, reversible switch between the two steady states, 
thus switching between two decisions.  
Bistability has been studied in signaling pathways governing cell fate decisions 
such as initiation of receptor-induced apoptosis by caspase activation [145], 
hematopoietic stem cell differentiation by the PU1 - GATA1 genetic switch for the 
erythroid-myeloid lineage decision [146] and establishment of polarity in cells 
[147]. Bistability has been experimentally demonstrated in multiple pathways, 
including the activation of MAPK cascade for oocyte maturation [148], cdc2 
activation for mitosis induction [149] and in the JNK cascade for stress-induced 
apoptosis of the oocyte [150]. 
In the above examples of bistability, a yes/no decision at molecular level results 
in a sudden change of cell behavior at larger scale. However, many molecular 
systems show bistability without necessarily causing huge sudden change in cell 
behavior. Bistability can integrate multiple graded inputs into a robust trigger for 
change, even if the change appears gradual from the viewpoint of a much larger 
scale. Bistability in phosphorylation of EGFR served as a switch to amplify 
ligand-induced signaling [151], which could lead to gradual changes in cellular 
motility. It has been suggested that bistability in MAPK signaling contributes to 
long-term synaptic potentiation by regulating the level of local dendritic translation 
[152]. These molecular-level yes/no decisions are only apparent when viewed at 




Robustness analysis  
 
The parameters used in model construction may be from different literature 
sources and therefore might not be very accurate. Robustness analysis is a 
method to check that the parameter values used are robust and therefore to 
ensure that the end result of the model simulations can produce robust results.  
For the current research project mathematical modeling and dynamical theory 
have been used to explore the complex cross-talk between NO and RhoA 
signaling.!
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1.7  Specific Aims 
1. To study the role of NO in HGF-induced scattering of MDCK cells. 
2. To validate that HGF induces VASP phosphorylation at Ser239 in 
epithelial MDCK cells and that NO mediates it. 
3. To examine the role of eNOS-mediated VASP-Ser239 phosphorylation in 
cell-cell contact disruption during HGF-induced scattering. 
4. To investigate the mutual regulation of the eNOS\pVASP-Ser239 signaling 
and the small GTPase, RhoA . 
5. To build a computational model of the HGF-stimulated NO-RhoA network 
and explore the possibility of bistability. 
Choice of cell-system 
Madin-Darby Canine Kidney (MDCK) cells are an untransformed, immortalized 
dog kidney epithelial cell line. HGF-induced scattering of MDCK cells is a well-
established invitro system to study EMT in two-dimensional cell culture. The 
model provides a reductionist approach to examine the signaling pathways 















Chapter 2. Materials and 
Methods 
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2.1 DNA cloning techniques 
2.1.1 Polymerase Chain Reaction (PCR) 
For site-directed mutagenesis, PCR was done using high fidelity DNA 
polymerase PfuUltraTM (Stratagene) with specific primer pairs in DNA thermal 
cycler model iCycler (BIO-RAD). The components of a 50 µl reaction were as 
follows: 5 µl of 10! reaction buffer, 0.2 mM dNTPs, 5 ng DNA template, 1 µl of 10 
µM sense primer, 1 µl of 10 µM anti-sense primer, 1 µl of polymerase and topped 
up to 50 µl with distilled water (dH2O). The PCR reaction mix was subjected to 
the following typical PCR condition: initial denaturation at 94ºC for 5 min, followed 
by 35 cycles of denaturation at 94ºC for 30 seconds, annealing at 56ºC for 30 
seconds and extension at 72ºC for 1-4 minutes (1 minute per kb) and final 
extension at 72ºC for 10 minutes.  
2.1.2 Agarose gel electrophoresis  
The DNA electrophoresis was performed in 1% (w/v) agarose gel. The agarose 
powder (BIO-RAD) was dissolved in Tris-acetate Ethylene diamine-tetraacetic 
acid (EDTA) (TAE) buffer. SYBR" safe DNA gel stain (Life technologies) was 
added to the agarose solution at the ratio of 1:100,000. PCR product was mixed 
with 10! DNA loading dye (3.9 ml glycerol, 500 μl 10% (w/v) SDS, 200 μl 0.5 M 
EDTA, 0.025 g bromophenol blue, 0.025 g xylene cyanol ff in 10 ml total volume 
with dH2O) and run with a voltage of 5 V/cm for 20-30 minutes. The gel was 




The standard transformation was performed using calcium chloride-based 
chemically competent E.Coli DH5α cells [157].  The desired plasmid or ligation 
product was added to the competent cells and mixed by tapping. The mixture 
was incubated on ice for 30 minutes. Heat shock was done by incubation at 42ºC 
water bath for 90 seconds. The tube was then cooled on ice for 2 minutes. Then 
1 ml of Luria-Bertani (LB) media (5 g yeast extract, 10 g tryptone and 10 g of 
NaCl in 1 L of H2O) was added into the tube. The tube was incubated for an hour 
at 37ºC in a bacterial shaker shaking at 250 rpm. The cells were spun down, 
spread on a LB plate with 50 µg/ml ampicillin or other appropriate antibiotics and 
incubated at 37ºC overnight. 
2.1.4 Plasmid isolation  
The bacteria was cultured in 3 ml of LB medium with 50 µg/ml ampicillin or 
appropriate antibiotics at 37ºC overnight with vigorous shaking at 250 rpm in a 
bacterial shaker. The plasmid isolation was conducted based on the 
manufacturerʼs instructions (Axygen miniprep kit).  
2.1.5 DNA sequencing 
DNA sequencing was performed by BigDye® terminator (Applied Biosystems 
Inc.). The components for a 10 µl sequencing PCR are as follows: around 300 ng 
DNA template, 0.4 µl of 10 µM forward primer, 4 µl of the BigDye premix and 
dH2O. The PCR condition is 25 cycles of 96ºC for 30 seconds, 50ºC for 15 
seconds and 60ºC for 1 minute. The PCR product was purified by ethanol 
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precipitation. The 10 µl PCR product was mixed with 62.5 µl of ethanol, 3 µl of 3 
M sodium acetate and 24.5 µl dH2O. After 10 minutes, the mixture was spun 
down at 14,000 rpm for 15 minutes. The pellet was washed twice with 1 ml of 
70% ethanol and centrifuged at 13,000 rpm for 10 minutes. The pellet was air-
dried and resuspended in 13 µl of ABI HiDi formamide buffer. The solution was 
loaded into a 96 well reaction plate and sequencing was performed using the 377 
ABI PRISM automated DNA sequencer (Applied Biosystems Inc.). 
2.1.6 Plasmid constructs: 
eNOS constructs 
WT-eNOS-RFP and WT-eNOS-GFP were bought from the Addgene library 
(Plasmid: 22497). The plasmids were constructed and deposited in the Addgene 
library by William Sessa [158]. The construct comprised of monomeric RFP 
inserted into the bovine eNOS cDNA in pCDNA3 vector at the C-terminus.  
VASP constructs 
The vector for VASP-GFP was a gift from Ronen Zaidel-Barʼs lab (National 
University of Singapore) and consists of a full-length construct of human VASP 
complementary DNA fused into the Clontech vector EGFP-C2.  
The VASP mutants used in this work were generated as follows. 
Generation of VASP point mutants 
Point mutants of VASP at Serine 239 were generated by site-directed 
mutagenesis using the QuickChange kit (Stratagene, La Jolla, CA) according to 
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the manufacturerʼs instructions. The following are the primers used to mutate the 
plasmid (the mutated codons are underlined):  
VASP-Ser239Ala  
Forward primer : CTCAGGAAAGTCGCCAAGCAGGAGGAGGCC 
Reverse primer : GGCCTCCTCCTGCTTGGCGACTTTCCTGAG 
VASP-Ser239D 
Forward primer : CTCAGGAAAGTCGACAAGCAGGAGGAGGCC 
Reverse primer : GGCCTCCTCCTGCTTGTCGACTTTCCTGAG 
2.2 Cell Culture 
2.2.1 Cell culture and Transfection 
Madin-Darby Canine Kidney (MDCK) strain II cells were kindly provided by 
Dr Walter Hunziker from Institute of Molecular and Cell Biology, Singapore [159]. 
They were grown in high-glucose Dulbeccoʼs modified Eangle medium (DMEM, 
Hyclone) supplemented with 10% (v/v) fetal bovine. The cells were grown at 
37oC and 5% CO2 atmosphere. They were grown, maintained and manipulated 
according to the general regulations stipulated for the Biosafety Level 2 (BSL2).  
The cells were passaged every other day. When they reached around 70% 
confluence, MDCK were washed with PBS and treated with Trypsin-EDTA 
solution (Gibco). The dish was incubated at 37ºC incubator for 5-10 minutes till 
the cells detached from the plate. The trypsin-EDTA was neutralized using 
complete media. The cells were split at the passage ratio of 1:5. 
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Complete media without antibiotics was added to MDCK cells at 60-80% 
confluence in 12-well plates and the cells were transfected with 1 μg plasmid 
using Lipofectamine 2000 reagent.  
2.2.1 Cryopreservation and recovery of cell lines 
Cells at 80-90% confluence were trypsinized, resuspended in complete medium 
and spun down at 800 g for 3 minutes. The cell pellets were resuspended in 
culture medium containing 5% Dimethyl sulfoxide (DMSO). Around 2!106 cells 
were transferred into a 1 ml cryovial. Cryovials were sealed tightly and placed in 
Mr. Frosty (Thermo) before transferring into -80ºC freezer. After 24 h, the 
cryovials were transferred into liquid nitrogen tank. Cell recovery was performed 
by rapid thawing of the cryovials in a 37ºC water bath. The cells were centrifuged 
at 800 g for 3 minutes to remove DMSO and resuspended in fresh culture 
medium. After that, the cells were seeded onto a 10 cm dish for further incubation 
and growth. 
2.3 Cell assays  
2.3.1 Chemical treatments on cells 
NO was scavenged by treating the cells with 100 μM carboxy-PTIO. For NOS 
inhibition, cells were treated with 50 μM L-NAME (Sigma) for 20 minutes, 
followed by the experiment. For inhibition of ROCK activity, cells were treated for 




2.3.2 HGF-induced cell scattering assay 
MDCK cells were grown up to 50-60% confluence such that they formed 
medium-sized colonies carrying ~10 cells per colony. Then, growing in serum-
free media for 12 hours starved the cells. The cells were treated with 10-20 
ng/mL of Hepatocyte Growth Factor (HGF) (Sigma) in media containing 5% 
serum.  
For tracking the cell movement, the cell nuclei were stained with Hoechst dye 
(Sigma). The cells were then monitored in real-time using Nikon A1R microscope 
(20X objective) for 10 hours. The images were analyzed using the object tracking 
tool in iMaris software.  
2.3.3 Cadherin adhesion assay 
20 ng of recombinant Human E-Cadherin Fc Chimera (R&D Systems) was mixed 
with 10 ul of PBS with Mg2+ and Ca2+. This mixture was coated on glass 
coverslips and left at room temperature for 2 hours. The coverslips were then 
washed thrice with PBS. MDCK cells were seeded on these cadherin-coated 
coverslips. The experiments were done within 1 to 2 hours of seeding the cells on 
the cadherin coated substrate to ensure that the adhesion structures formed by 
the cell are cadherin-mediated and not integrin-mediated.  
2.3.4 Antibodies 
Rabbit polyclonal antibodies anti-pSer1177-eNOS, anti-pSer239-VASP, anti-
pSer473-Akt and anti-pThr308-Akt were purchased from Cell Signaling. Rabbit 
polyclonal anti-pSer188-RhoA was bought from Sigma. Mouse monoclonal 
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antibodies - anti-VASP and anti-Akt were from BD Transduction Laboratories; 
anti-GAPDH and anti-RhoA were from Sigma. All secondary antibodies 
conjugated with Alexa Fluor dyes (488,568 and 633) were from Invitrogen.  
2.3.5 Immunostaining 
MDCK cells were cultured on poly-D-lysine-coated glass coverslips. Cells were 
washed three times with PBS and fixed with 4% formaldehyde for 20 minutes at 
room temperature. After fixation, cells were washed three times with PBS and 
permeabilised with 0.3% Triton X-100 in PBS for 10 minutes at room 
temperature. Permeabilised cells were blocked with 5% bovine serum albumin in 
PBS for 60 minutes at room temperature. Cells were incubated with primary 
antibodies appropriately diluted in blocking buffer overnight at 4ºC . Samples 
were washed thrice with PBS, and then incubated with Alexa Fluor conjugated 
antibodies in blocking buffer (1:200 dilution) for 60 minutes at room temperature. 
To mount the cells to a glass slide, 7 μl of FluorSaveTM (Millipore) was applied on 
the slide and the coverslip with cells facing the slide was placed on it.  
2.3.6 Fixed sample imaging and image processing 
Cells were imaged using Nikon A1R confocal microscope equipped with 60 × and 
100 × oil immersion lenses.  
2.3.6.1 Quantification of VASP at cell-cell contacts and focal adhesions 
The VASP at cell-cell contacts and focal adhesions was identified using the 
ImageJ tracing tool. The intensities of VASP and phospho-VASP-Ser239 were 
measured in the identified regions. The phospho-VASP-Ser239 intensity was 
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normalized to the VASP intensity in the same region of interest. The average 
phospho-VASP to VASP ratio in the various regions of interest (cell-cell contact 
or focal adhesion or whole cell) in the HGF-induced cells was normalized to the 
corresponding ratio in similar regions of the untreated cells.  
2.3.6.2 Quantification of cadherin-based adhesions and cell spread area 
The VASP intensity at cadherin-based adhesions was used to identify the 
adhesion-like structures using the ʻAnalyze particlesʼ function in ImageJ software. 
The adhesions were counted and characterized using the ʻROI managerʼ in the 
same software. The cadherin-adhesions with a ʻferet diameterʼ greater than 25 
pixels were classified as big adhesions.  
The cell spread area was calculated using the same tool in Imagej software. The 
VASP intensity threshold was manipulated to identify the adhesions or the whole 
cell. 
2.3.6.3 Discontinuity index 
The intensity of E-Cadherin fluorescence at cell-cell contacts was measured 
using the line intensity scan function in NIS-Elements image analysis software.  
(Line properties). Experiments were performed three times and a minimum of 15 
contacts was analyzed per experiment. The continuity of the cell-cell contacts 
was quantified by counting the number of breaks (breaks being defined as the 
regions in the cell-cell contacts where the E-cadherin intensity is below 200 
fluorescence intensity units). The number of breaks in the cell-cell contact was 
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normalized to length of that cell-cell contact and this value has been referred to 
as the Discontinuity Index.  
2.4 Western Blotting 
2.4.1 Cell lysis 
Cells were lysed using RIPA buffer, which contains150 mM sodium 
chloride, 50 mM Tris-HCl pH 7.3, 0.25 mM EDTA, 1% (w/v) sodium deoxycholate, 
1% (v/v) Triton X-100, 50 mM sodium fluoride, 5 mM sodium orthovanadate, and 
protease inhibitors (Roche Applied Science). The cells were lysed in 150µl of 
RIPA buffer (used per well in Nunc 12-well cell culture dishes) on ice for 3-5 
minutes. The whole cell lysates were then centrifuged for 10 minutes in 4ºC at 
12000 rpm. For western blotting analysis the supernatant was mixed with SDS 
loading dye and boiled at 85ºC for 5 minutes. 
2.4.2 Sodium dodecyl sulfate - Polyacrylamide Gel Electrophoresis  
(SDS-PAGE) 
8 or 10% polyacrylamide gel was used according to the molecular weight of the 
protein band and was manually cast in Mini-PROTEAN" 3 Cell (BIO-RAD) SDS-
PAGE apparatus following the manufacturerʼs instruction. The gel was placed 
into the Mini-PROTEAN" 3 electrophoresis module assembly filled with the SDS-
running buffer (15 g/L Tris base, 72 g/L Glycine, pH 8.3, SDS 5g). The comb in 
the gel was gently removed. The protein marker (BIO-RAD) and samples were 
loaded into the wells. The electrical leads were connected to a power pack and 
run at 150 V for 1.5 hours. 
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2.4.3 Gel transfer 
Proteins separated by SDS-PAGE were transferred to the PVDF membrane 
(Millipore) by wet electroblotting transfer system (BIO-RAD). Briefly, the PVDF 
membrane was first activated by methanol for 2 minutes. Then the PVDF 
membrane, chromatography papers (Whatman) and foam pads were soaked in 
transfer buffer (25mM Tris, 195mM glycine, 0.1% (w/v) SDS, 20% (v/v) 
methanol). Gel covered by the membrane was sandwiched between 
chromatography papers on each side followed by a foam pad in the plastic 
holder. Care was taken to avoid bubbles getting trapped in this setup. Then the 
holder was inserted into the cassette placed inside the electrophoresis system. A 
bio-ice cooling unit was placed into the tank and the transfer buffer was poured 
into the tank. The protein transfer was performed at 100V at 4℃ for 2 h.  
2.4.4 Immunoblotting  
The PVDF membrane with transferred protein was placed in a plastic box and 
blocked by 10 ml of 1% BSA in 1! PBS with 0.1% tween-20 (PBST) at room 
temperature with gentle shaking for 1 hour. The blocking solution was replaced 
by the primary antibody with appropriate dilution prepared in 1% BSA in 1! PBST 
and shaken overnight at 4ºC. After incubation, the membrane was washed thrice 
with PBST for 5 minutes each on a shaker. The matching secondary antibody 
conjugated with HRP with 1:2500 dilution in 1% BSA in PBST was added to the 
membrane and shaken gently at room temperature for 1 hour. This was followed 
by five times washes with PBST for 5 minutes each.  
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2.4.5 Chemiluminescent detection 
After immunoblotting, the HRP activity was detected by enhanced 
chemiluminescent substrate (Pierce Biotechnology, Inc.). Equal volumes of the 
luminol/enhancer and the peroxide buffer were mixed and added on top of the 
membrane. After 5 minutes, the membrane was transferred into the developing 
cassette and placed between transparency sheets. Signal detection was done by 
exposure to X-ray film (Fuji Photo Film) for appropriate time and developed in a 
RP X-OMAT Processor (Kodak). 
2.5 Statistical analysis  
Experiments were done in triplicate. Data were expressed as standard errors of 
the mean (±SEM). Statistical significance was determined using Studentʼs t-test. 

















3.1 Expression of NOS isoforms in MDCK cells !
As discussed earlier in Section 1.1, eNOS and nNOS are the constitutive NOS 
isoforms and iNOS expression is induced by cytokines and endotoxins. We 
characterized the expression of the three NOS isoforms (iNOS, eNOS and 
nNOS) in MDCK cells at basal conditions.  
Figure 3.1 RT-PCR expression analysis of NOS isoforms in MDCK cells.  
Total RNA isolated from MDCK cells was used as a template for the RT-PCR of 
iNOS (Lane 2), eNOS (Lane 3) and nNOS (Lane 4) transcripts. PCR products 
were separated on agarose gel. The sizes of the amplified transcripts were 860 
bp, 600 bp and 980 bp for iNOS, eNOS and nNOS respectively. Primers directed 
against GAPDH (Lane 1) generated a 600 bp fragment that was used as a 
positive control. Positions of molecular weight markers (in bp) are shown on the 
left.  
 
We compared the bands of the amplified transcripts of the three NOS isoforms 
(Figure 3.1). The band for the eNOS transcript was the brightest, the iNOS 
transcript band was faint and there was no visible band for nNOS. This result 
suggests that eNOS and iNOS are present in MDCK cells at basal conditions. 
We cannot, however, conclude the absence of nNOS in MDCK cells. We will 
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need to do further experiments to confirm the relative expression levels of the 
three NOS isoforms at basal and HGF-stimulated conditions. 
 In this thesis, we have studied the role of NO in MDCK cells by modulating the 
level of NO by different methods. We have used NO scavenger (carboxy-PTIO), 
NOS inhibitor (L-NAME) and eNOS over-expression studies. L-NAME shows a 
10 to 30-fold higher selectivity for the constitutive NOS isoforms (nNOS and 
eNOS) [160]. We have focused on over-expression studies using eNOS as its 
role in HGF-induced migration of endothelial cells is well-documented (reviewed 
in Section 1.1). Also, eNOS was found to be the most abundant constitutive 
NOS isoform in our RT-PCR study in MDCK cells. However, further experiments 
will be needed to study the relative roles of the three NOS isoforms in the HGF-
induced scattering of MDCK cells. 
3.2 Nitric oxide mediates HGF-induced scattering of MDCK cells 
As reviewed earlier in Section 1.2, it is useful to study the role of NO in the HGF-
induced scattering assay, which offers an insight into the function of NO in EMT. 
We addressed the question using three different methods to modulate the level of 
NO in HGF-induced MDCK cells: (3.2.1) Depletion of endogenous NO using 
carboxy-PTIO (3.2.2) Inhibition of NOS activity using L-NAME (3.2.3) Over-
expression by transient transfection of eNOS-RFP. 
We have grown MDCK cells, under conditions such that they form medium-sized 
colonies each containing 10 to 25 cells. These cells were stimulated using 20 
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ng/mL of HGF and their movements were tracked over a period of 10 hours 
under a fluorescence microscope.  
3.2.1 Depletion of NO blocks HGF-induced scattering of cells !
We used carboxy-PTIO to inhibit the effects of NO. Carboxy-PTIO belongs to a 
class of NO scavengers known as nitronyl nitroxides that react stoichiometrically 
with NO, thus inhibiting it [161].  
Figure 3.2 Depletion of endogenous NO blocks HGF-induced scattering 
of MDCK cells.  
(A to H) Images of a colony of MDCK cells stably expressing Lifeact-Ruby at 
various time points after HGF (20 ng/mL) stimulation. (A to D) Control MDCK 
cells treated with HGF (20 ng/mL) only. (E to H) MDCK cells pre-treated with 
carboxy-PTIO (100 μM) for 30 minutes, followed by HGF (20 ng/mL). 
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We used MDCK cells stably expressing Lifeact-Ruby, which labels actin. Cells 
were depleted of NO by treating with the NO inhibitor, carboxy-PTIO (100 μM) for 
30 minutes and then stimulated using 20 ng/mL of HGF. The cells were imaged 
under a fluorescence microscope.  
NO depletion prevented the scattering of MDCK cells whereas the control cells, 
treated with HGF alone, scattered in 3 to 6 hours (Figure 3.2).  This finding 
suggests that NO is needed for scattering. The depletion of endogenous NO 
using carboxy-PTIO has been found to affect several signaling pathways, other 
than NO and induce stress response in cells [162]. Therefore, we next confirmed 
our finding by inhibiting only NOS activity.  
3.2.2 Inhibition of endogenous NOS activity decreased HGF-induced 
scattering of cells 
L-NAME is a Nω-derivative of L-Arginine and inhibits NO synthesis by NOS by 
competing with the substrate, L-Arginine. L-NAME shows a 10 to 30-fold higher 
selectivity for the constitutive NOS isoforms (nNOS and eNOS) [160]. The 
inhibitory effect of L-NAME is 2-fold lesser than carboxy-PTIO [161]. Hence the 
effect of L-NAME is not as potent as carboxy-PTIO. We quantified the cell 
migration by measuring the track length of the cells. 
We stained the nuclei using DAPI and imaged the cells under a fluorescence 
microscope for 10 hours. The tracks were computed and analyzed using iMARIS.  
Upon inhibition of nitric oxide synthase using L-NAME (50 μM) there was a 2.5 
fold decrease in the distance travelled by the scattering cells (Figure 3.3). This 
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implies that constitutive NOS activity contributes to the migration of MDCK cells 
upon HGF stimulation. 
Since our study focuses on eNOS-related functions in MDCK cells, we checked 
the effect of over-expressing eNOS in the scatter assay. 
Figure 3.3 Scattering of cells upon HGF induction is regulated by NOS.  
The six bars on the graph represent the track length or the distance covered by 
MDCK cells subjected to each of the following treatment: (1) with no treatment 
(Untreated/Control); treated with (2) L-NAME 50 μM, (3) HGF 20 ng/mL, (4) HGF 
20 ng/mL and L-NAME 50 μM; (5 and 6) treated with HGF 20 ng/mL, transiently 
transfected with (5) GFP and (6) eNOS-RFP.  The experiment was done thrice 
and the the total number of cells(n) for each treatment is mentioned in 
parentheses in the x-axis label of the plot.  **p<0.005 
 
3.2.3 eNOS over-expression increased HGF-induced scatter 
We transiently transfected MDCK cells with eNOS-RFP and analyzed the 
migratory capacity of these cells upon HGF induction. MDCK cells over-
expressing eNOS moved to a greater distance (~1.5 fold higher) when compared 
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to control vector-transfected cells (Figure 3.3). This finding suggests that eNOS 
positively regulates the HGF-induced scattering process.  
 
We have shown that NO mediates HGF-induced scattering of MDCK cells using 
different methods to modulate NO level. However the underlying molecular 
mechanism needs to be dissected. Since scattering involves a tug-of-war 
between cell-cell and cell-substrate adhesions, we then looked at the impact of 
NO depletion on cell-substrate adhesions.  
3.3 NO mediates focal adhesion disassembly 
!
 Figure 3.4 NO depletion increased the number of focal adhesions.  
(A and B) MDCK cells fixed and stained for paxillin (focal adhesion marker): (A) 
Control cells with no treatment and (B) Treated with 200 μM carboxy-PTIO for 6 
hours. (C) Graph represents the number of focal adhesions per cell. 
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Focal adhesions are integrin-mediated cell-substrate adhesions (discussed in 
Section 1.1) and their turnover is increased upon HGF induction. Paxillin, a well-
studied focal adhesion protein, is used to mark focal adhesions.  
We treated the cells with two different doses (100 μM and 200 μM) of the NO 
scavenger, carboxy-PTIO for 6 hours, fixed, stained the cells for endogenous 
paxillin and imaged them under the microscope. The number of focal adhesions 
per cell was quantified using ImageJ software. We observed a significant, dose-
dependent increase in the number of focal adhesions per cell (Figure 3.4) upon 
treatment with carboxy-PTIO. Depletion of NO resulted in an increase in the 
number of focal adhesions per cell. 
One explanation for the drastic difference in the number of focal adhesions could 
be reduced focal adhesion disassembly upon NO depletion. This could decrease 
the turnover of the focal adhesions and increase their total number in the cell. 
This indicates that focal adhesion disassembly could be one of the ways by 
which NO mediates migration of MDCK cells. However, these cells were not 
HGF-stimulated. A more extensive spatiotemporal analysis of focal adhesions is 
required to conclude the impact of NO on focal adhesion turnover.  
The following experiments focus on eNOS activation upon HGF stimulation.  
3.4 eNOS-Serine 1177 phosphorylation in HGF-induced 
scattering  
Phosphorylation of eNOS at serine 1179(in bovine) or serine 1177(in human) or 
serine 1176(in mouse) by an Akt-dependent, Ca2+-independent mechanism 
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enhances its activity to produce NO [163]. HGF-induced NO production is of 
interest in endothelial cells (ECs) due to its implication in angiogenesis and it has 
been shown that the HGF-stimulated NO production is via rapid (~2-3 minutes) 
eNOS phosphorylation at serine 1179 in Bovine Aortic ECs (BAECs) [71, 72]. 
Based on our finding that eNOS positively regulates HGF-induced scattering 
(Section 3.2.3), we were interested to find if eNOS is activated by 
phosphorylation at Serine 1177 upon stimulation by HGF and the time course of 
the activation. Following studies also examine the cellular localization of eNOS 
and phospho-eNOS-Ser1177. 
3.4.1 HGF induces eNOS phosphorylation at Serine 1177 
Freshly seeded MDCK cells were left to adhere to the glass substrate for 3 hours 
and then starved for 12 hours, followed by the experiment. The cells were 
stimulated with the specified dose of HGF for varying durations and then lysed. 
By Western blot we detected the eNOS phosphorylation level in the cells. The top 
band was chosen for analysis. The lower band was not visible in all the 
experiments and could be a product of degradation. We could not find a suitable 
antibody to label pan-eNOS protein in MDCK cells and hence used GAPDH 
bands for normalization.  
We detected an increase in phospho-eNOS-Ser1177 as early as 1 minute post-
HGF induction (Figure 3.5). At low concentration of HGF (1 ng/mL), there was a 
short decay at 15 minutes post HGF addition.  
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Figure 3.5: HGF induces eNOS phosphorylation at Serine 1177 
 (A,B) MDCK cells were starved for 12 hours and stimulated using HGF 1ng/mL 
for different durations as indicated. The cells were lysed and their proteins were 
analyzed by western blot. (A) The samples were probed using anti-pSer1177-
eNOS in the first panel and anti-GAPDH in the second panel. (B) The pSer1177-
eNOS bands in the western blot were quantified using ImageJ, normalized with 
respect to GAPDH bands and plotted in the graph. ** indicates p<=0.005 
 
Since protein localization studies can offer more insight into the functional 
aspects, we proceeded to check the localization of eNOS and phospho-eNOS in 
the cell.  
3.4.2 HGF-induced eNOS phosphorylation is preferentially enriched 
at cell-cell contacts 
Cellular localization of eNOS and eNOS phosphorylation has been a study of 
importance in the vascular system. In microvascular and macrovascular ECs, 
eNOS associates with PECAM-1 at cell-cell contacts [46, 164]. Angiopoietin-1 
induced eNOS-Serine 1177 phosphorylation at cell-cell contacts in confluent 
HUVEC cells [165]. Vascular permeability depends upon cell-cell junction 
disruption and the VEGF-induced vascular permeability was found to be reduced 
in eNOS-S1176A (phospho-dead) mice compared to WT and eNOS-S1176D 
!! C?!
(phospho-mimetic) mice [65] (Serine 1176 is the mouse-equivalent site to Serine 
1177). Cell-cell junction disruption is one of the early events in HGF-induced 
scatter. The localization of active eNOS at the cell-cell contacts is important for 
specific targeting by NO. Hence we suspected if phospho-eNOS-Ser1177 
localizes at cell-cell contacts of MDCK cells.  
MDCK cells were transiently transfected with eNOS-GFP and observed under the 
fluorescent microscope. In another experiment, we stained control and HGF-
treated MDCK cells for endogenous phospho-eNOS-Ser1177 and viewed them 
under the microscope. The HGF dose used was 15 ng/mL and the treatment 
duration was 15 minutes. We detected the localization of transfected eNOS-GFP 
and endogenous eNOS-pSer1177 at the cell-cell contacts of MDCK cells (Figure 
3.6).  
Figure 3.6: eNOS and phospho-eNOS-Ser1177 localize to cell-cell 
contacts.  
(A) MDCK cells were transiently transfected with eNOS-GFP and observed under 
the microscope. (B)  MDCK cells were fixed after HGF treatment (15 ng/mL for 
15 minutes) and stained to detect endogenous phospho-eNOS-Ser1177 and 
observed under the microscope. 
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This finding suggests that there is a heightened release of NO at cell-cell 
contacts, which could modify proteins at cell-cell contact upon HGF induction. 
The cytoskeletal proteins targeted by NO at cell-cell contacts are not known.
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3.5 Role of NO in HGF-induced phosphorylation of VASP at 
Serine 239 
VASP is a cytoskeletal protein that localizes to cell-cell as well as focal contacts 
and plays a complex role in migration(reviewed in Section 1.3). VASP is a 
known target of NO and is phosphorylated at Serine 239 by NO/cGMP/PKG 
pathway. Phosphorylation of VASP at Serine 239 affects its binding to actin 
(discussed in Section 1.3.4). However, the function of VASP-Ser239 
phosphorylation in migration is not understood yet.  Hence we were interested to 
check if VASP-Ser239 phosphorylation affects HGF-induced scatter and if NO 
mediates this phosphorylation. First, we examined the VASP-Ser239 
phosphorylation profile upon HGF activation in MDCK cells. 
3.5.1 HGF induces VASP phosphorylation at Serine 239 
Freshly seeded MDCK cells were starved and treated using HGF as described 
earlier (in Section 3.4.1). The cells were lysed and by Western blot analyses, we 
detected endogenous VASP and phospho-VASP-Ser239. There was rapid 
phosphorylation of VASP at Serine 239 as early as 1 minute after the addition of 
HGF 1 ng/mL (Figure 3.7). The VASP phosphorylation peaked at 15 minutes and 
then rapidly decayed at 30 minutes (~6 fold decrease). This phosphorylation 
trend was seen consistently across a range of HGF concentrations from low (1 
ng/mL) to high (20 ng/mL).  
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Figure 3.7 HGF induces VASP phosphorylation at Serine 239 in MDCK 
cells.  
MDCK cells were treated with HGF (1ng/mL) for different durations as indicated. 
The cells were lysed and their proteins were analyzed using Western blot. (A) 
The samples were probed using anti-phospho-VASP-Ser239 (first panel), VASP 
(second panel) and GAPDH (third panel). (B) The phospho-VASP-Ser239 bands 
in the western blot were quantified using ImageJ, normalized with respect to 
VASP bands and plotted in the graph. ** indicates p<=0.005 
 
The short burst of VASP Serine239 phosphorylation immediately upon HGF 
induction suggests that it could be important for the early event of the scattering 
process. Cell-cell junction disruption is one of the early events of scattering and it 
is possible that VASP phosphorylation plays a role in it. Before verifying this 
hypothesis, we wanted to see if NO mediates the VASP phosphorylation at 
Serine 239, downstream of HGF activation. 
3.5.2 NO mediates HGF-induced VASP phosphorylation at Serine 239 
We addressed the question using two different methods to modulate the level of 
NO in HGF-induced MDCK cells: (3.5.2.1) By inhibiting the activity of constitutive 
NOS isoforms using L-NAME (3.5.2.2) Over-expression by transient transfection 
of eNOS-RFP. 
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3.5.2.1 Depletion of NO decreased VASP Ser239 phosphorylation 
Figure 3.8 L-NAME inhibits HGF-induced VASP Serine239 
phosphorylation.  
MDCK cells were treated with HGF (1ng/mL) for different durations with or 
without pre-treatment with L-NAME (50 μM) as indicated. The cells were lysed 
and their proteins were analyzed using Western blot. (A) The samples were 
probed using anti-phospho-VASP-Ser239 (first panel), VASP (second panel) and 
GAPDH (third panel). (B) The phospho-VASP-Ser239 bands in the western blot 
were quantified using ImageJ, normalized with respect to VASP bands and 
plotted in the graph.  
 
Freshly seeded MDCK cells were starved and treated using HGF as described 
earlier (in Section 3.4.1). Pre-treatment with L-NAME (50 μM) for 15-20 minutes 
was done to inhibit the activity of constitutive NOS isoforms. The cells were 
stimulated using HGF (1 ng/mL) for various durations and were lysed. By 
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Western blot analyses, we detected endogenous VASP and phospho-VASP-
Ser239 (Figure 3.8). 
There was almost no phosphorylation of VASP at Serine 239 when the cells were 
treated with a combination of L-NAME and HGF. This implies that the HGF-
induced VASP-Ser239 phosphorylation is mediated by the activity of constitutive 
NOS isoforms. Next, we checked VASP phosphorylation in eNOS-over-
expressing cells. 
3.5.2.2 Over-expression of eNOS increased VASP Serine 239 
phosphorylation level 
      
 A       B 
Figure 3.9 eNOS over-expression increase VASP-Ser239 
phosphorylation.  
MDCK cells were transiently transfected with eNOS-RFP, fixed and then stained 
with anti-phospho-VASP-Ser239 and Hoechst dye. The cells were then observed 
under the microscope. (A and B) The blue channel indicates Hoechst stain that 
labels the nuclei. (A) The red channel represents eNOS-RFP (B) The green 
channel represents phospho-VASP-Ser239. The scale bars are as indicated. 
 
MDCK cells were transiently transfected with eNOS-RFP, fixed and stained for 
phospho-VASP Ser239. eNOS-RFP over-expressing cells showed greater 
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phospho-VASP-Ser239 levels as compared to the untransfected cells. This 
suggests that eNOS upregulates VASP phosphorylation at Serine 239.  
We were then interested in the localization of the HGF-induced VASP 
phosphorylation.  
3.5.3 HGF-induced VASP phosphorylation at Serine 239 is 
preferentially enriched at cell-cell contacts  
Freshly seeded MDCK cells were starved for 12 hours and treated with HGF (10 
ng/mL) for 1 minute. The cells were fixed and stained for VASP, phospho-VASP-
Ser239 and phalloidin (to label actin). We then imaged the cells under confocal 
microscope. The maximum intensity projection of the Z-slices was done (Figure 
3.10) and the image was analyzed using ImageJ. We derived the fold change in 
the phospho-VASP/VASP ratio upon HGF induction in cell-cell contacts, focal 
adhesions and the whole cell as described in Section 2.3.6.1. 
The HGF-induced VASP-Ser239 phosphorylation at the cell-cell contacts and 
focal adhesions was compared to the global increase in the whole cell. The 
phosphorylation was found to be 26% more enriched at focal adhesions and 38% 
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Figure 3.10 HGF-induced VASP-Ser239 phosphorylation is preferentially 
enriched at cell-cell contacts and focal adhesions.  
MDCK cells were treated with HGF(10 ng/mL) for 1 minute, fixed and stained 
with (A) anti-phospho-VASP-Ser239 (B) phalloidin and (C) VASP. The phospho-
VASP-Ser239 and VASP intensities at the regions of interest were measured, 
normalized and the fold change was calculated as described in the text in 
Section 2. (D) The fold change in phospho-VASP/VASP ratio in HGF-induced 
cells as compared to untreated cells at cell-cell contacts, focal adhesions and the 
whole cell are plotted. * indicates p<=0.05 and ** indicates p<=0.005 
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This finding suggests that the VASP-Ser239 phosphorylation might have some 
functional role in modifying cell-cell contacts and focal adhesions upon HGF 
induction. To test this hypothesis, we proceeded to study the impact of mutating 
the Ser239 residue in VASP on cell-cell contacts.  
3.6 Phosphorylation of VASP at Serine 239 disrupts E-cadherin-
mediated cell-cell contacts 
VASP is known to mediate the sealing of epithelial cell-cell junctions (reviewed in 
Section 1.3). We therefore examined the role of VASP-Ser239 phosphorylation 
in the continuity of the cell-cell junctions. Plasmids with point-mutations directed 
against VASP-Ser239 were constructed as described in Section 2.1.6. These 
mutated GFP-tagged plasmids were used to study the role of Ser239 
phosphorylation at cell-cell contacts. 
3.6.1 Phosphorylation of VASP at Serine 239 affects the integrity of E-
cadherin-mediated cell-cell contacts 
MDCK cells stably transfected with E-cadherin-mcherry were used for this 
experiment. The cells were transiently transfected with VASP-GFP, VASP 239A-
GFP (phosphodead) and VASP 239D-GFP (phosphomimicking) mutants and 
induced with HGF (15 ng/mL) for 30 minutes. The cells were then fixed and 
imaged using a confocal microscope. The Discontinuity Index (DI), which is a 
measure of the number of breaks in the junctions, was measured as described in 
Section 2.3.6.3.  
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The DI was ~4 times higher in VASP239D-transfected cells than in the 
VASP239A-transfected cells, with or without HGF induction. This finding implies 
that VASP-Ser239 phosphorylation disrupts the continuity of cadherin-mediated 
cell-cell contacts. We further confirmed the finding using the E-cadherin substrate 
adhesion assay.  
     A 
 
Figure 3.11 VASP-Ser239 phosphorylation disrupts the continuity of 
cadherin-mediated cell-cell contacts.  
E-cadherin mCherry-stably transfected MDCK cells transiently transfected with 
the respective plasmids were treated with HGF as specified, fixed and imaged 
under the microscope. The Discontinuity Index (DI), which represents the number 
of breaks in the cell-cell junction, was quantified as explained in Section 2.3.6.3 
(A) The DI for the cells with different treatments is compared. a,b,c represent 
pairwise comparisons with p<0.05; bb represents p<0.005. 
 
3.6.2 Phosphorylation of VASP at Serine 239 impacts the size and 
number of cadherin-mediated adhesive contacts 
The cadherin planar adhesion assay can be used to study the early cadherin 
adhesive contacts. In this assay, cells are seeded on glass coverslips coated 
with hE/Fc, which is a recombinant protein comprising the complete ectodomain 
of human E-cadherin fused to the Fc-region of human IgG. The assay procedure 
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is described in detail in Section 2.3.3. E-cadherin-expressing cells spread on 
hE/Fc-coated substrates in a cadherin-dependent manner, with no contribution 
from integrins [166]. As the cells adhere, they form cadherin-adhesive contacts 
that vary in size from fine puncta to large clusters. Measuring the number and 
size of these contacts provides a convenient method to address the strength and 
efficiency of the cadherin homophilic binding of the cells.  
MDCK cells transiently transfected with VASP-GFP, VASP 239A-GFP and VASP 
239D-GFP plasmids were allowed to adhere to cadherin substrate for an hour (as 
described in Section 2.3.3) and then fixed. The cells were imaged under a 
confocal microscope. The maximum intensity projection of the Z-slices was 
obtained and the properties (size of the adhesions and number of adhesions per 






Figure 3.12 VASP-Ser239 phosphorylation affects the size and number 
of cadherin-based adhesions. 
(A-C)MDCK cells transiently transfected with (A)VASP-GFP (B)VASP-S239A-
GFP and (C)VASP-S239D-GFP were seeded on cadherin-coated glass slides 
and fixed after 1 hour. The cells were imaged and quantified as described in 
Section 2.3.6.2. The three kinds of VASP plasmid-transfected cells were 
compared for (D) Number of cadherin-based adhesions per cell (E)Number of 
long cadhesions per cell (F) Maximum length of cadhesion per cell and (F)Cell 






The spreading efficiency of the cells was measured from the area to which the 
cells had spread. VASP-239A-transfected cells spread better (by ~41%) and had 
more (~2-fold) number of cadherin adhesions per cell when compared to the 
VASP-239D-transfected cells. We then compared the size of the biggest 
adhesion in VASP-239D-transfected cells with the biggest adhesion in VASP-
239A-transfected cells and found it to be  ~30% smaller in the VASP-239D-
transfected cells. Based on a size parameter described in Section 2.3.6.2 , 
adhesions were classified as big or small. The number of big cadherin-adhesions 
per cell was less (by ~2-fold) in VASP-239D-transfected cells than VASP-239A-
transfected cells. 
These findings imply that VASP-239A-transfected cells adhere to the cadherin 
substrate better than VASP-239D-transfected cells. It is interesting to note that 
the phosphodead (VASP-239A) mutant caused an increase in cell-spread area 
and in the number of the cadherin-adhesions while the phosphomimicking 
(VASP-239D) mutant affected the size of the cadherin-adhesions, when 
compared to wild-type VASP-transfected cells.  
We have confirmed that VASP-Ser239 phosphorylation contributes to the 
disruption of cadherin-mediated cell-cell contacts. We then wanted to check the 
effect of VASP-Ser239 phosphorylation on HGF-induced migration as well as the 
concerted role of eNOS in this process. 
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3.7 eNOS-dependent VASP phosphorylation at Serine 239 
mediates HGF-induced scattering  
MDCK cells were transiently transfected with (a)GFP(control), (b)VASP-GFP, 
(c)VASP-S239A-GFP,(d)VASP-S239D-GFP(e)eNOS-RFP and co-transfected 
with (f)eNOS-RFP and VASP-GFP and (g)eNOS-RFP and VASP-S239A-GFP. 
The cells were starved for 12 hours. We stained the nuclei using DAPI, induced 
the cells with HGF (15 ng/mL) and imaged the cells under a fluorescence 
microscope for 10 hours. The tracks were computed and analyzed using iMARIS.   
Figure 3.13 eNOS-dependent VASP-Ser239 phosphorylation mediates 
HGF-induced migration 
MDCK cells transfected with GFP(control), eNOS RFP, eNOS-RFP+VASP-GFP, 
eNOS-RFP+VASP-S239A-GFP, VASP-GFP, VASP-S239A-GFP and VASP-
S239D-GFP were starved and induced with HGF 15 ng/mL. The cells were 
stained for DAPI and imaged under microscope for 10 hours. The migration was 
quantified by measuring the track length of the cells using iMARIS. The track 
length ( in uM) is plotted for the different treatments. The experiment was done 
three times. The total number of cells (n) measured for each treatment is given in 
parentheses in the x-axis. **p<0.005 
 
There was no difference in the migratory capacities of the VASP-transfected cells 
or the VASP-Ser239 phosphomutant-transfected cells. The eNOS-RFP-
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transfected cells were more motile as already shown in Section 3.2.3. The cells 
co-transfected with eNOS-RFP and VASP-GFP were also more motile than the 
other cells. However, the cells co-transfected with eNOS-RFP and VASP-S239A-
GFP were significantly less motile than cells transfected with eNOS-RFP alone or 
eNOS-RFP+VASP-GFP. 
The VASP-Ser239-mutants showed no change in cell motility. It does not, 
however, mean that they do not influence motility. The function of the 
endogenous VASP protein could be compensating for the mutants.  
These findings imply that VASP-Ser239 phosphorylation is needed for the 
increased motility of the eNOS-transfected cells upon HGF induction. We have 
shown that eNOS/NO signaling contributes to the HGF-stimulated scattering of 
epithelial cells by phosphorylating VASP at Serine 239, leading to cell-cell 
junction disruption. 
We have discussed in Section 1.4 about the cross-talk between NO and RhoA 
signaling. RhoA is an important cytoskeletal regulator, which mediates its 
downstream contractile effects by activating Rho Kinase (ROCK). We asked if 
the phosphorylation of VASP at Serine 239 could be regulated by the contractile 







3.8 Complex regulation of VASP-Ser239 phosphorylation by 
ROCK !
Figure 3.14 Complex regulation of VASP-Ser239 phosphorylation by 
ROCK. 
MDCK cells were induced with HGF 1ng/mL for the specified durations with or 
without pre-treatment with 20 uM Y-27632. The cells were lysed and their 
proteins were analyzed using Western blot. (A) The samples were probed using 
anti-phospho-VASP-Ser239 (first panel), VASP (second panel) and GAPDH (third 
panel). (B) The phospho-VASP-Ser239 bands in the western blot were quantified 





Freshly seeded MDCK cells were starved and treated using HGF as described 
earlier (in Section 3.4.1). Pre-treatment with Y-27632 (20 μM) for 30 minutes 
was done to inhibit the activity of ROCK. The cells were stimulated using HGF (1 
ng/mL) for various durations and then lysed. By Western blot analyses, we 
detected endogenous phospho-VASP-Ser239, VASP and GAPDH (Figure 3.14). 
We found that treatment with Y-27632 only increased the VASP-Ser239 
phosphorylation. However, the Y-27632 pre-treatment abolished the VASP-
Ser239 phosphorylation upon HGF induction. This finding led to questions on the 
regulation of the NO/cGMP pathway by RhoA/ROCK signaling.  
The mutual antagonism between NO and RhoA has been discussed earlier in 
Section 1.4. NO phosphorylates RhoA, thereby inhibiting its activity. RhoA, via 
ROCK activity, inhibits p-Akt/p-eNOS signaling as well as the stability of eNOS 
mRNA, thus downregulating NO. The NO-RhoA crosstalk has not been studied in 






3.9 ROCK inhibits p-Akt/p-eNOS signaling 
Freshly seeded MDCK cells were starved and treated using HGF as described 
earlier (in Section 3.4.1). Pre-treatment with Y-27632 (20 μM) for 30 minutes 
was done to inhibit the activity of ROCK. The cells were stimulated using HGF (1 
ng/mL) for various durations and then lysed. By Western blot analyses, we 
detected endogenous phospho-Akt-Ser473, phospho-Akt-Thr308, phospho-
eNOS-Ser1177, Akt and GAPDH (Figure 3.15).  
We found that Y-27632 treatment increased Akt and eNOS phosphorylation 
without HGF treatment and with HGF at early time-points (at 1 and 2 minutes). Y-
27632 treatment decreased Akt and eNOS activation at 30 minutes after HGF 
induction. (Figure 3.15). This finding implies that ROCK inhibits p-Akt/p-eNOS 
signaling in epithelial cells. The opposite effect at 30 minutes could be due to a 
feedback signaling mechanism. Thus we find that RhoA/ROCK signaling 
antagonizes NO release by inhibiting eNOS phosphorylation. We then proceeded 
to check if the converse is true, that is, if NO antagonizes RhoA by 
phosphorylating it at Serine 188 (reviewed in Section 1.4);' The mutual 








Figure 3.15 ROCK inhibits p-Akt/p-eNOS signaling. 
MDCK cells were induced with HGF 1ng/mL for the specified durations with or 
without pre-treatment with 20 uM Y-27632. The cells were lysed and their 
proteins were analyzed using Western blot. (A) The samples were probed using 
anti-pAkt-Ser473 (first panel), anti-pAkt-Thr308  (second panel) ,anti-peNOS-
Ser1177  (third panel), anti-Akt (fourth panel) and anti-GAPDH(fifth panel). (B 
and C) The phospho-Akt bands in the western blot were quantified using ImageJ, 
normalized with respect to Akt bands and plotted in the graph: (B) phospho-Akt-
Ser473 (C)phospho-Akt-Thr308 (D) The phospho-eNOS bands in the western 
blot were quantified using ImageJ, normalized with respect to GAPDH bands and 
plotted in the graph. **p<0.005 
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3.10 NO mediates HGF-induced phosphorylation of RhoA at 
Serine 188 !
Freshly seeded MDCK cells were starved and treated using HGF as described 
earlier (in Section 3.4.1). Pre-treatment with L-NAME (50 μM) for 15-20 minutes 
was done to inhibit the activity of constitutive NOS isoforms. The cells were 
stimulated using HGF (1 ng/mL) for various durations and then lysed. By Western 
blot analyses, we detected endogenous phospho-RhoA-Ser188, RhoA and 
GAPDH (Figure 3.16).  
Figure 3.16 NO mediates HGF-induced RhoA-Ser188 phosphorylation. 
MDCK cells were induced with HGF 1ng/mL for the specified durations with or 
without pre-treatment with 50 uM L-NAME. The cells were lysed and their 
proteins were analyzed using Western blot. (A) The samples were probed using 
anti-phospho-RhoA-Ser188 (first panel), RhoA (second panel) and GAPDH (third 
panel). (B) The phospho-RhoA-Ser188 bands in the western blot were quantified 
using ImageJ, normalized with respect to RhoA bands and plotted in the graph. 
**p<0.005. 
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We found that pre-treatment with L-NAME abolished the HGF-induced 
phosphorylation of RhoA at Serine 188. This implies that NO (cNOS) mediates 
the HGF-induced phosphorylation of RhoA at Serine 188.   
Our results imply that ROCK inhibits p-Akt/p-eNOS signaling and NO inhibits 
RhoA activity by phosphorylating it at Serine 188. We have shown the mutual 
antagonism of NO and RhoA in epithelial cells.  We then proceeded to model this 
complex pathway using computational tools to gain a better understanding of the 
network. 
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3.11 Model building: 
NO and RhoA are master-regulators of relaxation and contraction respectively. 
The NO-RhoA crosstalk has been discussed in detail earlier in Section 1.4. We 
have shown the mutual antagonism between NO and RhoA in MDCK cells 
(Sections 3.9, 3.10). We asked about the system-level implications of NO and 
RhoA antagonizing each other: if they would coexist in a stable balance, holding 
each other in check or if they would tend toward extreme levels with one 
predominant and the other suppressed? We questioned if the system can serve 
as a toggle switch between two different steady states that can lead to different 
phenotypes in the cell. 
HGF stimulation can activate both NO and RhoA, which leads to a complex 
network. We set to explore the possibility of the existence of bistability in the 
HGF-induced NO-RhoA network by computational modeling. We constructed a 
reaction network of the cross-talk between NO and RhoA (Figure 3.17) and 
converted these interactions into reaction rate equations (Table 3.1 ). The rates 
of change of concentrations of individual proteins have been modeled as 









A              B 
Figure 3.17: Overview of the HGF-activated NO-Rho network used in our 
pathway simulation model. 
 (A and B) The numbers on the arrows represent the reactions listed in Table 
3.1. The arrows in red represent fast inhibitory reactions and the arrow in orange 
represents a relatively slower inhibitory reaction. The reactions are described in 
detail in Section 1.4. The production and degradation reactions have not been 
shown in this representation. (B) Reactions 1-6 are depicted in detail. 
 
The following is an overview of the model presented in Figure 3.17. The reaction 
numbers appear in Figure 3.16 as well as Table 3.1. Reaction 10 represents the 
HGF-induced phosphorylation and activation of Akt to p-Akt. p-Akt mediates 
conversion of eNOS to p-eNOS and activates NO release (Reactions 8 and 9). 
The NO thus released is used in Reactions 1 to 6. The reactions 1 to 6, leading 
to cGMP production and the cGMP-induced negative feedback are depicted in 
detail in Figure 3.17B. Reactions 1 to 6 come from Yang et al [140] and 
represent the following (a-c) reactions: 
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(a) NO activates sGC (via three sGC intermediates Eb,E6c and E5c in 
Reactions 1 to 3. The total sGC concentration is conserved, that is, 
Eb+E6c+E5c=1) and leads to cGMP production (modeled using Michaelis-
Menten kinetics in Reactions 5 and 6).    
(b) cGMP limits itself by negative feedback (We used a cGMP feedback 
strength of m=1 and the corresponding parameter values as specified in 
[140] and represented in Reaction 4)  
(c) The cGMP-regulatory effect has been approximated using Hill equation as 
the Rcgmp term. The Rcgmp term satisfies the following property :  
Rcgmp  0 when [cGMP]  0 and Rcgmp 1 when [cGMP] approaches 
its maximal value. 
As described by Yang et al [140], we have used the Hill equation (Rcgmp) to 
describe the PKG-induced effect downstream of cGMP action. In our model, the 
Rcgmp term is used in the PKG-induced phosphorylation of RhoA-Ser188 
(Reaction 12). RhoA-Ser188 phosphorylation depletes active RhoA.  
At the same time, HGF-induced RhoA activation (Reaction 11) leads to ROCK 
activation. We have simplified the RhoA-mediated conversion of inactive ROCK 
to active ROCK as merely production of active ROCK from RhoA (Reaction 13). 
ROCK inhibits Akt phosphorylation (Reaction 16). Active RhoA inhibits eNOS 
mRNA stability and this is represented using a RhoA-dependent negative rate 
constant in the production of eNOS mRNA (Reaction 17).  We have assumed 
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that the total RhoA concentration is conserved (i.e. [Active RhoA]+[phospho-
RhoA]+[Inactive RhoA]=constant). 
A constant production of eNOS mRNA (Reaction 23) and a constant input of HGF 
were given to prevent the steady state concentrations of the species from 
decaying to zero. We added degradation terms for all the species except RhoA 
and sGC (because the total concentrations of RhoA and sGC are conserved in 
the system). The degradation terms represent the molecular degradation or 
inactivation (in the case of ROCK) (Reactions 24 to 32). Reactions 19 to 22 
represent the spontaneous degradation or the phosphatase-induced inactivation 
of the molecular species. 
The parameters and initial concentration values for Reactions 1 to 6 as well as 
the Hill equation (Rcgmp) come from Yang et al [140]. The NO concentration 
used by Yang et al [140] was a constant input of 220 nM. In our model, we have 
modified the production of NO to vary with time by deriving it from eNOS 
phosphorylation/activation.  
The remaining rate parameter values were adjusted to balance the antagonism 
between NO and RhoA. The steps followed for this exercise has been described 
in Procedure 2. The parameters were chosen such that the system converged to 
a steady state as time tends to infinity. The following procedures have been used 




3.11.1 Procedures followed for computational methods 
Procedure 1.  The test for bistability "# The concentrations of the species in the system were initialized to 
extreme, non-physiological levels, which were selected arbitrarily from 
ʻNO-highʼ extreme and ʻRhoA-highʼ extreme levels (Table 3.3). 7# For each set of initial concentrations (NO-high or RhoA-high), the ODE 
equations were solved to compute the trajectories of the species over 
time, until the system converged to steady state.   $# The steady state concentration of RhoA after initialization with the NO-high 
conditions, and the steady state concentration of RhoA after initialization 
with the RhoA-high conditions were used to compute the difference Dss 
between RhoA steady states.    ?# If the absolute difference was greater than 0.0001, the system was 
considered to be bistable, otherwise it was considered to be monostable. 
Procedure 2: Search parameter space for bistability 
We considered the model to consist of two sides: the NO side, which was 
comprised of all the reactions that favored high NO levels; and the RhoA side, 
with all the reactions that favored high active RhoA levels in the system. We 
explored a range of parameter values such that we balanced the strength of the 
two sides.  We did this because, if the antagonism was stronger from one 
direction, it can end up in one side more dominant than the other in the 
competition of mutual repression and the system would be monostable toward 
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that side. Monostable behaviors are relatively straightforward and less likely to 
contribute to higher order dynamic regulation of the cell.  
We balanced both sides (NO side and RhoA side) by tuning comparable levels of 
antagonism of NO by RhoA and vice-versa. The parameter tuning process was 
partly manual and partly automated. Step 3 of the following procedure was run 
automated for a range of rate parameter values. The good parameter values 
were selected according to the Dss  value computed, which were then refined 
manually as per steps 1 and 2 of the above procedure. "# If the difference Dss computed in step 3 of ʻThe test for bistabilityʼ protocol 
was negative, it meant that the reaction rate parameters on the ʻRhoA 
sideʼ were higher and hence the parameters had to be readjusted to 
increase the strength of the ʻNO sideʼ relative to the ʻRhoA side.ʼ   This 
was achieved by decreasing ki1 (the rate of ROCK antagonizing phospho-
Akt) or increasing k15 (the rate of cGMP-mediated phosphorylation of 
RhoA at Ser 188.) 7# If the difference computed in step 3 of ʻThe test for bistabilityʼ protocol was 
small and positive, it meant that the parameters on the ʻNO sideʼ were 
higher and hence the parameters had to be readjusted to increase the 
strength of the ʻRhoA sideʼ. This was achieved by increasing ki1 or 
decreasing k15, the opposite of above. $# The test for bistability was run.  
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?# If the system was monostable, the parameter tuning process was 
repeated. 
Procedure 3: Random generation of 100 initial conditions "# In the bistable model, get the two different steady state concentrations for 
all the species. 7# Compute the mid-value between the two steady state concentrations for 
all the species. $# The values obtained in step 2 must be used as means of the normal 
probability distribution to generate 100 different values for every species 
with a standard deviation of 0.25.  ?# These 100 different sets of initial concentrations of species were then 
used for simulating the model until steady states were achieved. K# The trajectories of RhoA until steady state were plotted against time. 
Procedure 4: Robustness analysis (By single parameter variation) "# A parameter was changed up or down by the specified percentage value. 7# The test for bistability was run.  $# This process was repeated for every percentage change in parameter 
value as follows:  increase or decrease by 3%,6%,10%,15%,30%. ?# Red box indicates presence of bistability and blue box indicates that the 




Procedure 5: Bifurcation analysis 
We used Matcont which is a MATLAB software package for our bifurcation 
analyses. The change in the steady state concentration of a model species in the 
model, versus change in the value of a reaction rate parameter, was computed in 
the bifurcation analysis.  The steady state species concentration was plotted 
against the parameter value.  







Reactions and values 1 to 7 : From Yang et al [140] 
1  
 
Eb + NO E6c 
k1=2000 
k11=100 
2  E6c  E5c k2=0.1 
3  E6c + NO E5c + NO k3=3 
 
4  E5c Eb + NO m=1 k4 = 0.098 * (cGMPm) 
5  
GTP+E5c GTP.E5c cGMP + 
E5c 
VmaxsGC=1.09 Vp= VmaxsGC * E5c 
6  
cGMP + PDE  cGMP.PDE                  
   GMP + PDE 
Kmpde=2 
kpde=0.032 
Vd =  
Vmaxpde = kpde*cGMP 
7  eNOSmrna eNOS kprod=0.5 
8  eNOS + pAkt  peNOS k7=0.1 
9  peNOS  NO k8=0.8 
10  Akt + hgf  pAkt k5=2.5 
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13  Rho_act ROCK k12=1 
14  ROCK tension k9=0.2 
15  Rho_inact + tension Rho_act k10=0.07 
Inhibition 
16  ROCK  pAkt ki1=2.1 
17  Rho_act
! 
ki2" # " eNOSmrna ki2=1 
18  NO
! 
k16" # " tension k16=0.76 
 
19  peNOS  eNOS kpp=0.01 
20  NO  kpp1=0.4 
21  Rho_act Rho_inact k13=0.1 
22  pRho  Rho_inact krest2=1 
Production 
23   eNOSmrna kbase=5 
Degradation 
24  cGMP  kdeg10=0.9 
25  NO  kdno=0.01 
26  NO  kdegNO=0.5 
27  eNOSmrna  kdeg7=0.5 
28  eNOS  kdeg8=0.99 
29  peNOS  kdeg3=0.9 




31  ROCK  kdeg4=0.99 
32  Tension  kdeg11=0.5 
 
 
The ODEs described in the Table 3.2 were simulated in MATLAB with the ODE 
solver ode15s. By integrating the ODEs over time, the trajectory of the 
concentration of every species over time can be obtained. The model is 
simulated till the concentrations reach steady state, which is the condition where 
there is no further change in concentrations with respect to time.  








1. [Eb]= -(k1*Eb*NO) + (k11*E6c) + (k4*E5c) 1,4 
2. [E6c] = (k1*Eb*NO) - (k11*E6c) - (k2*E6c) – (k3*E6c*NO) 1,2,3 
3. [E5c] = (k3*E6c*NO) + (k2*E6c) - (k4*E5c) 2,3 
4. [cGMP] = Vp –Vd – (kdeg10 *cGMP) 5,6 








8. [peNOS]=(k7*pAkt*eNOS)-(kdeg3*peNOS)-(kpp*peNOS) 8,9,19,29 








12. (ROCK)=(k12*Rho_act)-(kdeg4*ROCK) 13,14,16,31 
13. (pRho)=(k15*Rcgmp*Rho_act)-(krest2*pRho) 12,22 
14. (tension)=(k9*ROCK)-(kdeg11*tension)-(k16*NO*tension) 14,15,18,32 
ʻNormalʼ initial concentrations (in μM) used for model simulation: Eb=1; 
eNOSmRNA=5; Rho_inactive=8 ; Akt=2.5; HGF=0.01. Initial concentrations of all 
the other species were 0 μM.  




Initial concentration for 
NO-high state (μM) 
Initial concentration for 
RhoA-high state (μM) 
eNOS mRNA 100000 5 
Active RhoA 0 8 
!! YC!
pSer188-RhoA 8 0 
p-Akt 100000 0 
ROCK 0 100000 
Tension 0 100000 
 
3.12 Model Simulation 
3.12.1 Testing the qualitative behaviour of the model 
As described in Procedure 2, we estimated the parameters to model comparable 
levels of antagonism from both directions. We were able to model the initial peak 
and decline in the p-Akt/p-eNOS/NO (Figure 3.18 blue curve), which is similar to 
the trend observed in in vitro experiments. We then ran tests to check the model 
behavior. We perturbed key species by simulating treatments with L-NAME 
(cNOS inhibitor), Y-compound (ROCK inhibitor) and tension (RhoA activator). We 
did not try to match absolute concentrations of the species, but looked for the 
system to reproduce the qualitative behaviour of the experiments.  
In Figure 3.18, we show that by simulating Y-27632 treatment (by a 50% 
reduction in rate of production of ROCK), we obtained higher levels of NO. This 
behavior is similar to in vitro observations. By simulating L-NAME treatment 
(reduction of rate of p-eNOS conversion to NO by 50%), we obtained decreased 
pSer188-RhoA levels (Figure 3.19). This is similar to our experimental results in 
Section 3.10. Thus we performed a ʻsanity-checkʼ of our model and verified that 
the qualitative behaviour of the system is as expected. 
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Figure 3.18: Simulation of the effect of Y-27632 treatment on NO 
concentration.  
The NO concentration curves are depicted: with no treatment (blue curve) and on 
simulating Y-27632 treatment (red curve). 
 
               
Figure 3.19 Simulation of the effect of L-NAME treatment on RhoA 
concentration.  
The phospho-RhoA concentration curves are as depicted: with no treatment (blue 
curve) and on simulating L-NAME treatment (red curve). 
 
3.12.2 Bistability in the model 
 Manual tuning of the rate parameters in search of the bistable regime was 
completed as per Procedure 2, followed by checking the logical behaviour of the 
model. We then proceeded to characterize the bistable behavior of the model. As 
described in Procedure 3, we generated 100 random initial concentrations for all 
the species. Each of these 100 sets of initial conditions was simulated using the 
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ODE solver until the system reached steady state. In Figure 3.20, the system 
reaches two different steady state concentrations of active RhoA depending on 
the initial concentrations given to the model. This result implies that the system is 
capable of bistability. In a bistable system, the steady state of the system 
depends on the initial conditions of the system. We then performed the 
bifurcation and robustness analyses to study the nature and extent of the bistable 
regime in the model.  
 
Figure 3.20 Model simulation of random initial concentrations 
Random initial concentrations of the species converge to two different steady 







3.12.3 Bifurcation analysis 
Bifurcation analysis is used to determine the boundaries of parameters that allow 
a system to remain bistable. The bifurcation analysis was done as explained in 
Procedure 5. The bifurcation curves of NO were S-shaped as expected for 
bistable systems (Figure 3.21).  
Figure 3.21 Bifurcation analysis of the model 
The graphs are plotted with (A,B) NO concentration against the parameters 
(A)ki1 and (B)ki2. !
3.12.4 Robustness analysis 
We then analysed the robustness of the model to learn what parameters 
determine the bistability.  We followed Procedure 4 to analyze the robustness of 







Figure 3.22 Robustness analysis of the bistability in the NO-RhoA model 
 The parameters were varied by the specified percentage value and the system 
was checked for bistability. Red boxes denote presence of bistability while blue 
boxes denote the absence of bistability  
 
We find that bistability of the system is brittle. The bistability was robust to 
changes in a few parameters such as kdno, kmpde, kpde, nHcgmp, kpp and 
krest2 which mostly represent the degradation or inactivation of NO, 
eNOSmRNA, p-eNOS or cGMP. The bistability of the system was very sensitive 




parameter perturbations.  
We also found that some parameters disrupt bistability if we changed them in 
either direction (up or down), suggesting that the parameter vector is near the 
center of the bistable region, for that dimension. Some parameters disrupted 
bistability only if we shifted them in one direction and not the other, suggesting 
that, in that parameterʼs dimension of the parameter space, the parameter vector 
we selected (the unchanged values) happens to be near the edge of the bistable 
region.   
3.13 Integrating the effect of mechanical tension in the model 
NO and RhoA are master regulators of relaxation and contraction respectively. 
The cytoskeletal effects on NO and RhoA are partly a consequence of their 
opposite effects on mechanical tension. There are multiple links between 
mechanical tension and the biochemical system of NO and RhoA signaling as 
shown in reactions 14,15 and 18 of Fig.3.23. RhoA effector, ROCK increases 
MLC phosphorylation directly [167] as well as in an indirect manner by 
phosphorylating and inactivating myosin phosphatase [168]. MLC 
phosphorylation increases myosin binding to actin and thus increases contractile 
tension. Mechanical tension activates RhoA [169, 170] and this leads to a 
positive feedback mechanism to amplify and sustain ROCK activity [141]. Hence 
culturing cells on a rigid substrate elevates RhoA activity [171]. In contrast to the 
Rho/ROCK/myosin pathway, NO can decrease tension and is a well-studied 
vasodilator [172-174]. The NO/cGMP pathway inhibits MLC phosphorylation by 
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decreasing intracellular Ca2+ levels [174], activating K+ channels [175] and by 
activating MLCP [176]. In summary, NO and RhoA have opposite effects on 
cytoskeletal tension. We proceeded to check if these reactions of NO, RhoA and 
tension can contribute to the bistability of the model. We added three new 
reactions to the previous model : (Reaction 14) ROCK increases tension ; 
(Reaction 15) Tension increases active RhoA level; (Reaction 18) NO decreases 
tension. The reactions and rate constants for reactions 14,15 and 18 are given in 
Table 3.1 and the respective ODEs are in Table 3.2. 
 
 
Figure 3.23 Overview of the updated NO-RhoA model upon addition of 
the effects of tension.  
(Reactions 15-18) 
 
3.13.1 Bistability in the model 
For the updated model, we repeated the manual tuning of the rate parameters in 
search of the bistability as per Procedure 2. We then characterized the bistability 
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of the new model. 100 random initial concentrations were generated for all the 
species as described in Procedure 3. Each of these 100 sets of initial conditions 
was simulated using the ODE solver until the system reached steady state. In 
Figure 3.24, the system reaches two different steady state concentrations of 
active RhoA depending on the initial concentrations given to the model. This 
result implies that the system is capable of bistability. We then performed the 
bifurcation and robustness analyses to characterize the bistability. 
 
Figure 3.24 Random initial concentrations of the species converge to 
two different steady state concentrations of active RhoA. 
 
3.13.2 Bifurcation analysis 
The bifurcation analysis was performed for the new model as explained in 
Procedure 5. The bifurcation curves of NO were S-shaped which is characteristic 
of bistable systems. Below are the bifurcation analyses for the parameters ki1 




Figure 3.25 Bifurcation analyses of the NO-RhoA model.  
The change in steady state NO concentration with the change in the value of 
parameter ki1 is plotted for (A) Model without ʻtensionʼ reactions (B) Updated 
model with ʻtensionʼ reactions. 
 
3.13.3 Robustness analysis 
We then analyzed the robustness of the model to learn what parameters 
determine the bistability of the new model. The parameters were singly varied by 
the specified percentage value and the system was checked for bistability as 






Figure 3.26 Robustness analysis of the bistability in the updated NO-
RhoA model.  
The parameters were varied by the specified percentage value and the system 
was checked for bistability. Red boxes denote presence of bistability while blue 
boxes denote the absence of bistability. 
 
The robustness analysis revealed that the bistability of the model had increased 
to a great extent. The bistability of the system remained unbroken for 10 to 15% 
perturbation in 33 out of 36 parameters. The bistability was sensitive to 6% 
variation of Kmcgmp (parameter in cGMP regulatory effect – Hill equation), k12 
(production rate constant of ROCK) and kdeg4 (degradation rate constant of 
ROCK). The cGMP regulatory effect (Hill equation) is used to model the 
phosphorylation of RhoA by cGMP. The three parameters (Kmcgmp,k12, kdeg4) 
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that have a greater effect on the bistability belong to the ʻRhoA-sideʼ of the 
model. 
3.14 Implications of the NO-RhoA bistability model analysis 
The bifurcation analyses of the first model (Fig.3.21) showed that the bistable 
regime lies between 0.5 to 8 nM of NO. Upon integrating the effects of ʻtensionʼ 
and repeating the bifurcation analyses, we find that the bistable regime now 
extends from around 1 nM up to 60 nM of NO (Fig.3.25). The bistable regime has 
enlarged considerably in the updated model and the NO concentration is closer 
to that used in Yang et al [140], which was obtained from physiological 
conditions. The robustness of the bistability in the earlier model was brittle and 
sensitive to only 3% variation in most of the parameters (Fig.3.22). However, in 
the new model, the robustness of the bistability is greater and the system 
remains bistable for 10 to 15% variation in most of the parameters (Fig.3.26). We 
can conclude that since the bistability in the NO-RhoA network is decently robust 
in silico, it is likely to exist in vitro as well. Furthermore, the bistability might not 
exist in conditions where the tension-RhoA positive feedback loop or the tension-
NO reactions are absent, for example, in suspension cell cultures. 
The following modifications could be incorporated in the model and might make 
the model resemble in vitro conditions more closely. 
(i) The NO/cGMP-induced VASP-Ser239 phosphorylation can activate Rac1 
[97], which antagonizes RhoA activity. These reactions need to be added 
to our model to determine their effect on bistability.  
!! "EP!
(ii) NO upregulates RhoA expression (reviewed in Section 1.). If included, 
this reaction can affect the long-term dynamics of the model.  
(iii) We have not included the NO-induced S-nitrosylation of RhoA (which 
inactivates RhoA) and the NO-induced nitration of p190RhoGAP (which 
upregulates active RhoA level). The speed, strength and the necessary 
NO levels for these reactions are not clear.  We chose to omit them from 
the model, both because they are poorly understood and also because 
they have opposite effects on RhoA, so omitting is like assuming they 
cancel each other out.  
(iv) The HGF concentration used in our in vitro experiments is 0.0001 μM but 
in our computational model, we have used a much higher concentration of 
0.01 μM of HGF. Most of the rate constants in the model were chosen 
arbitrarily. If the parameter values could be estimated from experimental 
data and if the model was then evaluated for bistability, that would provide 
more useful predictions for experimental design. 
Bistability in NO-RhoA signaling in vitro 
To prove bistability, the system must be shown to exhibit two different steady 
states depending on two different initial states, without changing the reaction 
rates in the system. The following is an example of an experiment to test for 
bistability in vitro. 
For the two different initial states, the NO concentration can be set low or high.  
The NO concentration can be varied in vitro using an NO donor. Cells in each of 
the two different states can then be treated with varying concentrations of ROCK 
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inhibitor, Y-27632 (5-30 uM) and the steady state NO level can be measured 
using an assay kit. For very low and very high amounts of Y-27632 added, the 
steady state NO concentration would be the same in both cases. However, in the 
intermediate concentrations of Y-27632, the ʻlow-NOʼ initial state would converge 
to a lower NO steady state concentration than the ʻhigh-NOʼ initial state. In the 
same experiment, the steady state RhoA concentration can also be measured to 
show bistability. If the steady state RhoA level was measured using Glisa kit for 
the two different cases, the ʻlow-NOʼ initial state would converge to a higher 
RhoA level than in the ʻhigh-NOʼ initial state.  
In the above experiment, the global level of NO or active RhoA were perturbed or 
measured. However, the local RhoA activity can be measured using the RhoA 
biosensor and this can be useful to test bistability in spatiotemporal phenomena 
such as focal adhesion turnover. It could also be useful to test bistability 
spatiotemporally by perturbing the local activity of the protein using optogenetics 












4.1 Brief Summary of Results 
In our research project, we have studied the role of NO in the cytoskeletal 
remodeling during the HGF-induced scattering of MDCK cells. We have shown 
that NO is needed for the HGF-induced migration of epithelial cells. Our findings 
suggest that NO could regulate the focal adhesion turnover during cell migration. 
We have also shown that the NO-mediated phosphorylation of VASP at Serine 
239 disrupts the cell-cell junctions and thereby contributes to the cell scattering 
upon HGF stimulation. Consistently, the increased motility of eNOS-
overexpressing cells was rescued on co-transfecting the cells with the phospho-
dead (Ser239A) mutant of VASP. 
The p-Akt/p-eNOS signaling is known to increase NO/cGMP/PKG activity and 
thus phosphorylate VASP at Serine 239. We have demonstrated the mutual 
antagonism between the RhoA/ROCK signaling and the p-Akt/p-eNOS pathway 
in epithelial cells. However, we discovered that ROCK activity is needed for HGF-
induced VASP-Ser239 phosphorylation in MDCK cells. We suspect that a novel 
feedback mechanism is involved in this network. 
We have modeled the complex set of interactions in the NO-RhoA signaling 
cross-talk using computational tools. The model behaviour was tested and 
parameters were tuned to replicate experimental results in a qualitative manner. 
Upon further analysis, we found that the system is capable of converging to 
bistability. Robustness analysis was done to study the effect of parameter 
perturbations on the system and we found that the model was robust.  
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4.2 Future directions 
Future studies need to focus on studying the relative roles of the three NOS 
isoforms in epithelial cell migration. Our findings suggest the involvement of NO 
in the focal adhesion turnover during migration. Further spatiotemporal studies 
are needed to test the function of NO as well as NO-induced VASP 
phosphorylation in focal adhesions during cell migration. The differential 
phosphorylation status of VASP at cell-cell contacts and focal adhesions can 
throw light on the cross-talk between cell-cell and focal adhesions. This would 
lead to a better understanding of the role of NO in the scattering phenomenon.  
We found that ROCK inhibition increased VASP-Ser239 phosphorylation in 
uninduced cells but decreased HGF-induced VASP-Ser239 phosphorylation. 
However, we do not know the mechanism behind this regulation. Future work 
would focus on extensive literature mining for the existence of any known 
negative feedback mechanism, followed by experimental work to explain this 
regulation.  
We have built a computational model of the NO-RhoA interaction network and 
found that it is capable of converging to bistability. To see if the bistability exists 
in physiological conditions, it will have to be tested experimentally in cells. It can 
be done in many ways using the commercially available chemicals to manipulate 
and the assays to measure NO and RhoA activity in cells. One example of an 




4.3 Overall insight into the role of NO/VASP signaling in cancer 
EMT is a critical process in embryonic development, as well as in tumor 
metastasis. EMT is characterized by the disassembly of cell–cell junctions and 
the induction of a migratory phenotype in epithelial cells that allows the cells to 
escape the surrounding epithelium and invade other tissues. It is less well 
understood how cell–cell contacts are disrupted during EMT. Using the well-
known in vitro model system for EMT, which is the HGF-induced scattering of 
MDCK cells, our study identifies the phosphorylation of VASP at Ser239 as a 
critical mediator of the effect of NO on scattering. We report for the first time that 
the NO-mediated VASP phosphorylation leads to cell-cell junction disruption 
during scattering. 
 Understanding the role of NO in cancer at the molecular level will have profound 
therapeutic implications for cancer treatment and prevention. NO modulates 
different cancer-related events including metastasis, invasion, angiogenesis, 
apoptosis and cell cycle. The actin cytoskeletal network plays a vital role in the 
invasive properties of oncogenic cells and VASP is crucial in directing actin 
polymerization. VASP was overexpressed in lung adenocarcinoma cells [86] and 
VASP overexpression in NIH3T3 fibroblasts was found to induce neoplastic 
transformation [87]. Control of the NO-regulated phosphorylation status of VASP 




4.3 Overall insight into the role of NO-RhoA crosstalk in migration 
The role of NO in cell migration is complex. NO is a highly reactive and diffusive 
molecule and hence needs to be tightly regulated in a spatiotemporal manner. 
The effects of NO on the cytoskeleton are dilatory in nature.  Conversely, RhoA is 
a protein that is a master regulator of cytoskeletal contraction.  Too much NO or 
too much RhoA can be detrimental to the integrity of the cytoskeleton and hence 
toxic to several cellular functions. Hence the mutual antagonism of NO and RhoA 
could keep a check on the other and hold the system in balance. On the other 
hand, there could exist a toggle switch in the cell to favour spatially controlled 
accumulation of either NO or RhoA and thus switch between relaxation and 
contraction. This could be useful for mechanosensing when the cell has to decide 
the direction of protrusion and movement as well as for cell polarity, which is 
important in differentiation, proliferation and morphogenesis of organisms. 
 The zones of ʻhigh-RhoAʼ or ʻhigh-NOʼ can play a role in focal adhesion turnover 
during migration. Focal adhesion turnover is a spatiotemporally controlled 
phenomenon in the cell. RhoA has been associated with focal adhesion growth 
while NO has been known to aid focal adhesion disassembly. Downstream of 
HGF induction, NO and RhoA are both activated and these two species with 
opposite effects on focal adhesions must be spatially controlled to favour 
migration. Our modeling result, that the NO-RhoA system is capable of bistability, 
could help to explain how the cell creates spatiotemporal domains or sharp 
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boundaries to regulate focal adhesion assembly and disassembly during motility 
events. 
 
In this thesis, we have studied the role of NO through VASP phosphorylation in 
epithelial cell migration, in a spatiotemporal context. Furthermore, we have used 
computational methods to show bistability in the NO-RhoA signaling interplay. 
We have answered many important questions as well as raised some new 
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3'+"',9#.'/0-$<3+&)$0-'3&':'+#"$-'$-$#(0(<-/0+0"1'30/-:<-+&0'"-)44'3'+<-+#=)"/-+&0-
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)-,&)"<:/#+#.'39$03$'+'C0-F-,&)330(-:<-,7E89/0%03/03+-%"#+0'3-A'3)$05!H,&2!.35)!G234!820!^!8!G;!"YY?#!Y:S"CTB!(#!PKR$LP#!"P?#! %3,V3f3);!]#G#;!*5!3)#;!E#(0,2()"-10,&)3'$1-#4-,7E8910/')+0/-$1##+&-12$,(0-
"0().)+'#35!]!%*))!H:960&);!7EEE#!:F?S$TB!(#!?EYL7E#!"PK#! Q&)&5013;!F#A#;!*5!3)#;!*'+"',-#.'/0-/'"0,+(<-),+'C)+0$-,)(,'219/0%03/03+-
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